|
OMIM |
Link |
Information gain |
01 |
|
HPC10
|
[NCBI]
|
0.00308411
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.00289156
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.00287535
|
|
|
MAFD6
|
[NCBI]
|
0.00278644
|
|
|
IBD5
|
[NCBI]
|
0.00217354
|
|
|
CRCS2
|
[NCBI]
|
0.00215492
|
|
|
autism
|
[NCBI]
|
0.0018114
|
|
|
CELIAC6
|
[NCBI]
|
0.00172908
|
|
|
SCZD7
|
[NCBI]
|
0.00171488
|
|
|
PSORS2
|
[NCBI]
|
0.00144983
|
|
|
VRNI
|
[NCBI]
|
0.00143553
|
|
|
IBD2
|
[NCBI]
|
0.00108593
|
|
|
PSORS5
|
[NCBI]
|
0.00107475
|
|
|
AUTS7
|
[NCBI]
|
0.00107475
|
|
|
HSCR9
|
[NCBI]
|
0.00107475
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.00107475
|
|
|
CHDS8
|
[NCBI]
|
0.00107475
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.0010717
|
|
|
ARMD4
|
[NCBI]
|
0.00105491
|
|
|
AUTS6
|
[NCBI]
|
0.000957781
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.000914159
|
|
|
MYP2
|
[NCBI]
|
0.00081275
|
|
|
leukemia, chronic lymphocytic, susceptibility to, 1
|
[NCBI]
|
0.000717249
|
|
|
wegener granulomatosis
|
[NCBI]
|
0.000717249
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000717249
|
|
|
AD15
|
[NCBI]
|
0.000717249
|
|
|
IBD8
|
[NCBI]
|
0.000717249
|
|
|
alzheimer disease 10
|
[NCBI]
|
0.000717249
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000717249
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000717249
|
|
|
ATFB5
|
[NCBI]
|
0.000717249
|
|
|
SHEP8
|
[NCBI]
|
0.000717249
|
|
|
FEB6
|
[NCBI]
|
0.000717249
|
|
|
HSCR8
|
[NCBI]
|
0.000717249
|
|
|
BMND7
|
[NCBI]
|
0.000717249
|
|
|
PSNP3
|
[NCBI]
|
0.000717249
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000656957
|
|
|
IBD1
|
[NCBI]
|
0.000647748
|
|
|
IDDM
|
[NCBI]
|
0.000646512
|
|
|
CF
|
[NCBI]
|
0.00063903
|
|
|
SHEP1
|
[NCBI]
|
0.000620036
|
|
|
AUTS9
|
[NCBI]
|
0.00060202
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.00060202
|
|
|
CFH
|
[NCBI]
|
0.000559247
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.0005411
|
|
|
COMT
|
[NCBI]
|
0.00051726
|
|
|
PARK3
|
[NCBI]
|
0.000514388
|
|
|
SCZD
|
[NCBI]
|
0.000473102
|
|
|
esophagitis, eosinophilic
|
[NCBI]
|
0.000456577
|
|
|
myopia 9
|
[NCBI]
|
0.000456577
|
|
|
DFNA41
|
[NCBI]
|
0.000456577
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000456577
|
|
|
myopia 7
|
[NCBI]
|
0.000456577
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000456577
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.000456577
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.000456577
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000456577
|
|
|
myopia 10
|
[NCBI]
|
0.000456577
|
|
|
myopia 8
|
[NCBI]
|
0.000456577
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000456577
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000456577
|
|
|
IBD7
|
[NCBI]
|
0.000456577
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000456577
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.000456577
|
|
|
EGF
|
[NCBI]
|
0.000442973
|
|
|
TCF7L2
|
[NCBI]
|
0.000436366
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000420007
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.000361018
|
|
|
pelvic organ prolapse
|
[NCBI]
|
0.000361018
|
|
|
cavitary optic disc anomalies
|
[NCBI]
|
0.000361018
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000361018
|
|
|
DYT15
|
[NCBI]
|
0.000361018
|
|
|
AUTS10
|
[NCBI]
|
0.000361018
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
0.000361018
|
|
|
PARK10
|
[NCBI]
|
0.000361018
|
|
|
ALSFTD2
|
[NCBI]
|
0.000361018
|
|
|
SHEP3
|
[NCBI]
|
0.000349609
|
|
|
IS1
|
[NCBI]
|
0.000338529
|
|
|
MAFD1
|
[NCBI]
|
0.000338176
|
|
|
HSCR1
|
[NCBI]
|
0.000312993
|
|
|
DYX5
|
[NCBI]
|
0.000300556
|
|
|
DYX3
|
[NCBI]
|
0.000300556
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000300556
|
|
|
MYP3
|
[NCBI]
|
0.000300556
|
|
|
asperger syndrome, susceptibility to, 1
|
[NCBI]
|
0.000300556
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000300556
|
|
|
DYX6
|
[NCBI]
|
0.000300556
|
|
|
MCDU
|
[NCBI]
|
0.000300556
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000300556
|
|
|
muscular dystrophy, congenital, merosin-positive
|
[NCBI]
|
0.000300556
|
|
|
SCZD5
|
[NCBI]
|
0.000300556
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000300556
|
|
|
NGFB
|
[NCBI]
|
0.000291064
|
|
|
SCZD3
|
[NCBI]
|
0.00028932
|
|
|
SHEP5
|
[NCBI]
|
0.000259725
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000258029
|
|
|
CELIAC2
|
[NCBI]
|
0.000256763
|
|
|
AUTS5
|
[NCBI]
|
0.000256763
|
|
|
AD14
|
[NCBI]
|
0.000256763
|
|
|
AD13
|
[NCBI]
|
0.000256763
|
|
|
SCA4
|
[NCBI]
|
0.000256763
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000256763
|
|
|
lactase persistence
|
[NCBI]
|
0.000254752
|
|
|
SCZD9
|
[NCBI]
|
0.000252573
|
|
|
osteoarthritis
|
[NCBI]
|
0.000243577
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000222789
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000222789
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000222789
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000222789
|
|
|
ATOD6
|
[NCBI]
|
0.000222789
|
|
|
NIDDM2
|
[NCBI]
|
0.000222789
|
|
|
MS
|
[NCBI]
|
0.000220052
|
|
|
IL10
|
[NCBI]
|
0.000217439
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000217185
|
|
|
obesity
|
[NCBI]
|
0.000214895
|
|
|
LTA
|
[NCBI]
|
0.00021334
|
|
|
PSORS4
|
[NCBI]
|
0.000195302
|
|
|
TPH2
|
[NCBI]
|
0.000194869
|
|
|
NRG1
|
[NCBI]
|
0.000191952
|
|
|
PRL
|
[NCBI]
|
0.000187462
|
|
|
prostate cancer
|
[NCBI]
|
0.000187412
|
|
|
NIDDM
|
[NCBI]
|
0.000185215
|
|
|
MCM6
|
[NCBI]
|
0.000175993
|
|
|
IBD10
|
[NCBI]
|
0.000173129
|
|
|
SHEP4
|
[NCBI]
|
0.000173129
|
|
|
gastroesophageal reflux
|
[NCBI]
|
0.000172426
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000172426
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000172426
|
|
|
ARMD7
|
[NCBI]
|
0.000165022
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
0.000163992
|
|
|
PD
|
[NCBI]
|
0.000159273
|
|
|
DTNBP1
|
[NCBI]
|
0.000155684
|
|
|
GFAP
|
[NCBI]
|
0.000155664
|
|
|
MBL2
|
[NCBI]
|
0.000155588
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000155131
|
|
|
AITD3
|
[NCBI]
|
0.000155029
|
|
|
IDD
|
[NCBI]
|
0.000155029
|
|
|
SCZD6
|
[NCBI]
|
0.000152998
|
|
|
MAPT
|
[NCBI]
|
0.000146903
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
0.000146559
|
|
|
PCNA
|
[NCBI]
|
0.000145953
|
|
|
PTPN22
|
[NCBI]
|
0.000141813
|
|
|
RET
|
[NCBI]
|
0.00014157
|
|
|
CRC
|
[NCBI]
|
0.000141202
|
|
|
SLC22A4
|
[NCBI]
|
0.00013924
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
0.000139213
|
|
|
PTH
|
[NCBI]
|
0.000136963
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.000136247
|
|
|
TOC
|
[NCBI]
|
0.000136247
|
|
|
HPCX
|
[NCBI]
|
0.000136247
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
0.00013514
|
|
|
PPROM
|
[NCBI]
|
0.00013514
|
|
|
alcohol dependence
|
[NCBI]
|
0.000135042
|
|
|
VIP
|
[NCBI]
|
0.000133912
|
|
|
EPO
|
[NCBI]
|
0.000133641
|
|
|
IDE
|
[NCBI]
|
0.000130883
|
|
|
sarcoidosis
|
[NCBI]
|
0.000126938
|
|
|
KLK3
|
[NCBI]
|
0.000125677
|
|
|
TH
|
[NCBI]
|
0.0001253
|
|
|
NOD2
|
[NCBI]
|
0.000122323
|
|
|
OTSC1
|
[NCBI]
|
0.000121634
|
|
|
allergic rhinitis
|
[NCBI]
|
0.000118117
|
|
|
ACHE
|
[NCBI]
|
0.000117239
|
|
|
loc387715 gene
|
[NCBI]
|
0.000116748
|
|
|
ABCB1
|
[NCBI]
|
0.00011661
|
|
|
APC
|
[NCBI]
|
0.000113028
|
|
|
behcet syndrome
|
[NCBI]
|
0.000111828
|
|
|
PPR
|
[NCBI]
|
0.000111828
|
|
|
BTBD9
|
[NCBI]
|
0.000110583
|
|
|
CYP3A5
|
[NCBI]
|
0.000109467
|
|
|
IDDM10
|
[NCBI]
|
0.000106515
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
0.000106515
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.000106515
|
|
|
AFP
|
[NCBI]
|
0.000105949
|
|
|
BBS
|
[NCBI]
|
0.000104717
|
|
|
PDCD1
|
[NCBI]
|
0.000103488
|
|
|
ALOX5AP
|
[NCBI]
|
0.000103488
|
|
|
NPY
|
[NCBI]
|
0.000102164
|
|
|
IL4R
|
[NCBI]
|
0.000101073
|
|
|
CTLA4
|
[NCBI]
|
9.9149e-05
|
|
|
APOA5
|
[NCBI]
|
9.72836e-05
|
|
|
g30 gene
|
[NCBI]
|
9.5755e-05
|
|
|
CDKAL1
|
[NCBI]
|
9.5755e-05
|
|
|
ADAM33
|
[NCBI]
|
9.5755e-05
|
|
|
VDR
|
[NCBI]
|
9.49794e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
9.4896e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
9.4896e-05
|
|
|
INSIG2
|
[NCBI]
|
9.34878e-05
|
|
|
EGFR
|
[NCBI]
|
9.34299e-05
|
|
|
AVP
|
[NCBI]
|
9.16979e-05
|
|
|
PON1
|
[NCBI]
|
9.1417e-05
|
|
|
CCK
|
[NCBI]
|
9.07212e-05
|
|
|
asthma, nasal polyps, and aspirin intolerance
|
[NCBI]
|
9.05652e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
9.05652e-05
|
|
|
IRF5
|
[NCBI]
|
9.01467e-05
|
|
|
TLR4
|
[NCBI]
|
8.97789e-05
|
|
|
EIG
|
[NCBI]
|
8.9674e-05
|
|
|
g72 gene
|
[NCBI]
|
8.79765e-05
|
|
|
CAPN10
|
[NCBI]
|
8.66271e-05
|
|
|
SHEP6
|
[NCBI]
|
8.65542e-05
|
|
|
BULN2
|
[NCBI]
|
8.65542e-05
|
|
|
ciliary dyskinesia, primary, 6
|
[NCBI]
|
8.65542e-05
|
|
|
legionnaire disease, susceptibility to
|
[NCBI]
|
8.65542e-05
|
|
|
coronary heart disease, susceptibility to, 7
|
[NCBI]
|
8.65542e-05
|
|
|
IDDM19
|
[NCBI]
|
8.65542e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
8.65542e-05
|
|
|
PPNAD2
|
[NCBI]
|
8.65542e-05
|
|
|
PMSE
|
[NCBI]
|
8.65542e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
8.65542e-05
|
|
|
SHEP7
|
[NCBI]
|
8.65542e-05
|
|
|
qt interval, variation in
|
[NCBI]
|
8.65542e-05
|
|
|
polysubstance abuse, susceptibility to
|
[NCBI]
|
8.65542e-05
|
|
|
gallbladder disease 4
|
[NCBI]
|
8.65542e-05
|
|
|
CDSN
|
[NCBI]
|
8.50128e-05
|
|
|
OPLL
|
[NCBI]
|
8.46063e-05
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
8.46063e-05
|
|
|
PARK4
|
[NCBI]
|
8.46063e-05
|
|
|
APOE
|
[NCBI]
|
8.40677e-05
|
|
|
FGFR4
|
[NCBI]
|
8.34738e-05
|
|
|
FTO
|
[NCBI]
|
8.23148e-05
|
|
|
SLC30A8
|
[NCBI]
|
8.23148e-05
|
|
|
SUMO4
|
[NCBI]
|
8.23148e-05
|
|
|
IL23R
|
[NCBI]
|
8.23148e-05
|
|
|
thiourea tasting
|
[NCBI]
|
8.18301e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
7.94913e-05
|
|
|
NIDDM1
|
[NCBI]
|
7.94913e-05
|
|
|
HGF
|
[NCBI]
|
7.93897e-05
|
|
|
MG
|
[NCBI]
|
7.92866e-05
|
|
|
CD
|
[NCBI]
|
7.87179e-05
|
|
|
NPPA
|
[NCBI]
|
7.81315e-05
|
|
|
PAND1
|
[NCBI]
|
7.80565e-05
|
|
|
PLIN
|
[NCBI]
|
7.76523e-05
|
|
|
ADIPOR1
|
[NCBI]
|
7.76523e-05
|
|
|
DISC1
|
[NCBI]
|
7.6705e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
7.50175e-05
|
|
|
BDNF
|
[NCBI]
|
7.48277e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
7.34419e-05
|
|
|
ENPP1
|
[NCBI]
|
7.32308e-05
|
|
|
CRH
|
[NCBI]
|
7.23168e-05
|
|
|
graves disease
|
[NCBI]
|
7.15606e-05
|
|
|
FMO3
|
[NCBI]
|
7.11069e-05
|
|
|
kawasaki disease
|
[NCBI]
|
7.10478e-05
|
|
|
CMT2A2
|
[NCBI]
|
7.10478e-05
|
|
|
HTRA1
|
[NCBI]
|
7.08868e-05
|
|
|
NCSTN
|
[NCBI]
|
7.05767e-05
|
|
|
ARMD1
|
[NCBI]
|
7.03411e-05
|
|
|
IL13
|
[NCBI]
|
7.00957e-05
|
|
|
PLEKHG4
|
[NCBI]
|
6.96087e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
6.80159e-05
|
|
|
FCHL
|
[NCBI]
|
6.80159e-05
|
|
|
TCOF
|
[NCBI]
|
6.80124e-05
|
|
|
OPTN
|
[NCBI]
|
6.72418e-05
|
|
|
HNMT
|
[NCBI]
|
6.6345e-05
|
|
|
UBQLN1
|
[NCBI]
|
6.5599e-05
|
|
|
VEGF
|
[NCBI]
|
6.51536e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
6.42574e-05
|
|
|
HHEX
|
[NCBI]
|
6.336e-05
|
|
|
FCAS
|
[NCBI]
|
6.31756e-05
|
|
|
PLXNA2
|
[NCBI]
|
6.30282e-05
|
|
|
saitohin
|
[NCBI]
|
6.30282e-05
|
|
|
AD
|
[NCBI]
|
6.26385e-05
|
|
|
HTR2A
|
[NCBI]
|
6.25251e-05
|
|
|
HCRTR2
|
[NCBI]
|
6.13253e-05
|
|
|
MTHFD1
|
[NCBI]
|
6.13253e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
6.13111e-05
|
|
|
LEPR
|
[NCBI]
|
6.06188e-05
|
|
|
IPD1
|
[NCBI]
|
5.90484e-05
|
|
|
ARMD9
|
[NCBI]
|
5.90484e-05
|
|
|
metaphyseal dysplasia without hypotrichosis
|
[NCBI]
|
5.90484e-05
|
|
|
IS3
|
[NCBI]
|
5.90484e-05
|
|
|
HMPS2
|
[NCBI]
|
5.90484e-05
|
|
|
STQTL9
|
[NCBI]
|
5.90484e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
5.90484e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
5.90484e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
5.90484e-05
|
|
|
PTHS
|
[NCBI]
|
5.90484e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
5.90484e-05
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
5.90484e-05
|
|
|
MRD1
|
[NCBI]
|
5.90484e-05
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
5.90484e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
5.8604e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
5.8604e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
5.8604e-05
|
|
|
KCNJ11
|
[NCBI]
|
5.72708e-05
|
|
|
PRODH
|
[NCBI]
|
5.72708e-05
|
|
|
MYOC
|
[NCBI]
|
5.64723e-05
|
|
|
IGAN1
|
[NCBI]
|
5.57299e-05
|
|
|
proteus syndrome
|
[NCBI]
|
5.57299e-05
|
|
|
oca2 gene
|
[NCBI]
|
5.54297e-05
|
|
|
SLC12A8
|
[NCBI]
|
5.52865e-05
|
|
|
IGER
|
[NCBI]
|
5.48733e-05
|
|
|
IGF2BP2
|
[NCBI]
|
5.47226e-05
|
|
|
SORL1
|
[NCBI]
|
5.47226e-05
|
|
|
SLC45A2
|
[NCBI]
|
5.46595e-05
|
|
|
CAST
|
[NCBI]
|
5.46595e-05
|
|
|
breast cancer
|
[NCBI]
|
5.415e-05
|
|
|
DYX2
|
[NCBI]
|
5.37811e-05
|
|
|
DYT3
|
[NCBI]
|
5.37811e-05
|
|
|
longevity
|
[NCBI]
|
5.37811e-05
|
|
|
DHRD
|
[NCBI]
|
5.37811e-05
|
|
|
acromegaly
|
[NCBI]
|
5.37811e-05
|
|
|
PSEN2
|
[NCBI]
|
5.35137e-05
|
|
|
PPARG
|
[NCBI]
|
5.27518e-05
|
|
|
GPR154
|
[NCBI]
|
5.1733e-05
|
|
|
VKORC1
|
[NCBI]
|
5.1733e-05
|
|
|
PSORS1
|
[NCBI]
|
5.1635e-05
|
|
|
CHAT
|
[NCBI]
|
5.13112e-05
|
|
|
HIDS
|
[NCBI]
|
4.95918e-05
|
|
|
FGFR2
|
[NCBI]
|
4.94385e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
4.91443e-05
|
|
|
PWS
|
[NCBI]
|
4.91149e-05
|
|
|
OPTB4
|
[NCBI]
|
4.88333e-05
|
|
|
myocardial infarction, susceptibility to, 2
|
[NCBI]
|
4.88333e-05
|
|
|
ATOD4
|
[NCBI]
|
4.88333e-05
|
|
|
mandibulofacial dysostosis, treacher collins type, autosomal recessive
|
[NCBI]
|
4.88333e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
4.88333e-05
|
|
|
SLEB2
|
[NCBI]
|
4.88333e-05
|
|
|
RP26
|
[NCBI]
|
4.88333e-05
|
|
|
OPRM1
|
[NCBI]
|
4.87278e-05
|
|
|
LTC4S
|
[NCBI]
|
4.73954e-05
|
|
|
ADIPOQ
|
[NCBI]
|
4.71359e-05
|
|
|
GLC3A
|
[NCBI]
|
4.59018e-05
|
|
|
LRP5
|
[NCBI]
|
4.54341e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
4.42131e-05
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
4.42131e-05
|
|
|
VUR1
|
[NCBI]
|
4.41333e-05
|
|
|
chiari malformation type i
|
[NCBI]
|
4.41333e-05
|
|
|
PADI3
|
[NCBI]
|
4.39832e-05
|
|
|
SLC24A5
|
[NCBI]
|
4.39832e-05
|
|
|
PADI1
|
[NCBI]
|
4.39832e-05
|
|
|
MAGED2
|
[NCBI]
|
4.39832e-05
|
|
|
FCRL3
|
[NCBI]
|
4.39832e-05
|
|
|
F3
|
[NCBI]
|
4.3757e-05
|
|
|
SLC22A5
|
[NCBI]
|
4.36398e-05
|
|
|
ADH3
|
[NCBI]
|
4.33028e-05
|
|
|
CDKN2B
|
[NCBI]
|
4.33028e-05
|
|
|
MODY
|
[NCBI]
|
4.318e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
4.22936e-05
|
|
|
FIDD
|
[NCBI]
|
4.22936e-05
|
|
|
ARMD2
|
[NCBI]
|
4.22936e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
4.22936e-05
|
|
|
VAMAS1
|
[NCBI]
|
4.22936e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
4.22936e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
4.22936e-05
|
|
|
RD
|
[NCBI]
|
4.22936e-05
|
|
|
CELIAC4
|
[NCBI]
|
4.22936e-05
|
|
|
CHBL
|
[NCBI]
|
4.22936e-05
|
|
|
resting heart rate
|
[NCBI]
|
4.22936e-05
|
|
|
sarcoidosis, early-onset
|
[NCBI]
|
4.22936e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
4.22936e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
4.22936e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
4.22936e-05
|
|
|
LGMD2K
|
[NCBI]
|
4.22936e-05
|
|
|
CLN7
|
[NCBI]
|
4.22936e-05
|
|
|
MTR
|
[NCBI]
|
4.21472e-05
|
|
|
TNFRSF10A
|
[NCBI]
|
4.19876e-05
|
|
|
FCGR2B
|
[NCBI]
|
4.17262e-05
|
|
|
MTHFR
|
[NCBI]
|
4.13799e-05
|
|
|
VWS
|
[NCBI]
|
4.12462e-05
|
|
|
osteoporosis
|
[NCBI]
|
4.11011e-05
|
|
|
OLR1
|
[NCBI]
|
4.02875e-05
|
|
|
GGH
|
[NCBI]
|
3.8965e-05
|
|
|
P2RX7
|
[NCBI]
|
3.8965e-05
|
|
|
CHGB
|
[NCBI]
|
3.8906e-05
|
|
|
SRR
|
[NCBI]
|
3.8906e-05
|
|
|
SMA2
|
[NCBI]
|
3.82939e-05
|
|
|
ACE
|
[NCBI]
|
3.795e-05
|
|
|
GGCX
|
[NCBI]
|
3.7742e-05
|
|
|
OFC1
|
[NCBI]
|
3.75864e-05
|
|
|
ALSG
|
[NCBI]
|
3.74995e-05
|
|
|
IDDM12
|
[NCBI]
|
3.74995e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
3.74995e-05
|
|
|
DFNA10
|
[NCBI]
|
3.74995e-05
|
|
|
RTADR
|
[NCBI]
|
3.74995e-05
|
|
|
premature chromosome condensation with microcephaly and mental retardation
|
[NCBI]
|
3.74995e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
3.74995e-05
|
|
|
STL3
|
[NCBI]
|
3.74995e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
3.74995e-05
|
|
|
enterokinase deficiency
|
[NCBI]
|
3.74995e-05
|
|
|
CTPP3
|
[NCBI]
|
3.74995e-05
|
|
|
AVSD2
|
[NCBI]
|
3.74995e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
3.74995e-05
|
|
|
TRPS3
|
[NCBI]
|
3.74995e-05
|
|
|
GHRL
|
[NCBI]
|
3.70711e-05
|
|
|
ABCG2
|
[NCBI]
|
3.67677e-05
|
|
|
IRF6
|
[NCBI]
|
3.6605e-05
|
|
|
ELAC2
|
[NCBI]
|
3.6605e-05
|
|
|
SELE
|
[NCBI]
|
3.6605e-05
|
|
|
MDM2
|
[NCBI]
|
3.64573e-05
|
|
|
GDNF
|
[NCBI]
|
3.63261e-05
|
|
|
neural tube defects
|
[NCBI]
|
3.57443e-05
|
|
|
TGFB1
|
[NCBI]
|
3.55764e-05
|
|
|
FA
|
[NCBI]
|
3.55405e-05
|
|
|
TLR2
|
[NCBI]
|
3.54963e-05
|
|
|
CCL24
|
[NCBI]
|
3.54385e-05
|
|
|
ZDHHC8
|
[NCBI]
|
3.54385e-05
|
|
|
CYSLTR2
|
[NCBI]
|
3.54385e-05
|
|
|
ATG16L1
|
[NCBI]
|
3.54385e-05
|
|
|
ABCA12
|
[NCBI]
|
3.54385e-05
|
|
|
LMNA
|
[NCBI]
|
3.50261e-05
|
|
|
C5
|
[NCBI]
|
3.45475e-05
|
|
|
IL6R
|
[NCBI]
|
3.45475e-05
|
|
|
BHMT
|
[NCBI]
|
3.45475e-05
|
|
|
CAT
|
[NCBI]
|
3.42655e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
3.37335e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
3.37335e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
3.37335e-05
|
|
|
RP14
|
[NCBI]
|
3.37335e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
3.37335e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
3.37335e-05
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
3.37335e-05
|
|
|
RETN
|
[NCBI]
|
3.36107e-05
|
|
|
SPR
|
[NCBI]
|
3.36107e-05
|
|
|
MC1R
|
[NCBI]
|
3.35871e-05
|
|
|
CPB2
|
[NCBI]
|
3.35871e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
3.34415e-05
|
|
|
APOB
|
[NCBI]
|
3.3099e-05
|
|
|
CLEC16A
|
[NCBI]
|
3.27946e-05
|
|
|
BTNL2
|
[NCBI]
|
3.27946e-05
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
3.27946e-05
|
|
|
PADI4
|
[NCBI]
|
3.27946e-05
|
|
|
CALU
|
[NCBI]
|
3.27946e-05
|
|
|
GABRA4
|
[NCBI]
|
3.27946e-05
|
|
|
CASQ1
|
[NCBI]
|
3.27946e-05
|
|
|
DLG5
|
[NCBI]
|
3.27946e-05
|
|
|
FPLD2
|
[NCBI]
|
3.23244e-05
|
|
|
USF1
|
[NCBI]
|
3.21361e-05
|
|
|
LPL
|
[NCBI]
|
3.18715e-05
|
|
|
IL6
|
[NCBI]
|
3.12626e-05
|
|
|
FOXC2
|
[NCBI]
|
3.10953e-05
|
|
|
ALS1
|
[NCBI]
|
3.07831e-05
|
|
|
CAPN1
|
[NCBI]
|
3.06578e-05
|
|
|
BRD2
|
[NCBI]
|
3.06578e-05
|
|
|
MMP8
|
[NCBI]
|
3.06578e-05
|
|
|
CCL7
|
[NCBI]
|
3.06578e-05
|
|
|
ADIPOR2
|
[NCBI]
|
3.06578e-05
|
|
|
AIF1
|
[NCBI]
|
3.06578e-05
|
|
|
DYX1C1
|
[NCBI]
|
3.06578e-05
|
|
|
ADH4
|
[NCBI]
|
3.06578e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
3.06578e-05
|
|
|
FMO2
|
[NCBI]
|
3.06468e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
3.06468e-05
|
|
|
IDDM5
|
[NCBI]
|
3.06468e-05
|
|
|
HHRH
|
[NCBI]
|
3.06468e-05
|
|
|
body mass index
|
[NCBI]
|
3.06468e-05
|
|
|
CDG1C
|
[NCBI]
|
3.06468e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
3.06468e-05
|
|
|
LGMD2J
|
[NCBI]
|
3.06468e-05
|
|
|
LSFC
|
[NCBI]
|
3.06468e-05
|
|
|
CASR
|
[NCBI]
|
3.06435e-05
|
|
|
TNF
|
[NCBI]
|
3.05335e-05
|
|
|
TLR9
|
[NCBI]
|
3.04452e-05
|
|
|
ESR1
|
[NCBI]
|
3.04452e-05
|
|
|
CYP1B1
|
[NCBI]
|
3.034e-05
|
|
|
CASP8
|
[NCBI]
|
3.034e-05
|
|
|
TLR5
|
[NCBI]
|
3.02934e-05
|
|
|
MSTN
|
[NCBI]
|
2.98597e-05
|
|
|
TPMT
|
[NCBI]
|
2.97206e-05
|
|
|
SRD5A2
|
[NCBI]
|
2.89326e-05
|
|
|
LCT
|
[NCBI]
|
2.85039e-05
|
|
|
AGT
|
[NCBI]
|
2.82205e-05
|
|
|
GHR
|
[NCBI]
|
2.81876e-05
|
|
|
PARK7
|
[NCBI]
|
2.8043e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
2.8043e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
2.8043e-05
|
|
|
globozoospermia
|
[NCBI]
|
2.8043e-05
|
|
|
SC
|
[NCBI]
|
2.8043e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
2.8043e-05
|
|
|
JBTS3
|
[NCBI]
|
2.8043e-05
|
|
|
MCOPS2
|
[NCBI]
|
2.8043e-05
|
|
|
char syndrome
|
[NCBI]
|
2.8043e-05
|
|
|
SLEB1
|
[NCBI]
|
2.8043e-05
|
|
|
LADD
|
[NCBI]
|
2.8043e-05
|
|
|
CFTR
|
[NCBI]
|
2.77812e-05
|
|
|
ATF6
|
[NCBI]
|
2.76451e-05
|
|
|
ADH2
|
[NCBI]
|
2.76451e-05
|
|
|
NDRG3
|
[NCBI]
|
2.7642e-05
|
|
|
OR7D4
|
[NCBI]
|
2.7642e-05
|
|
|
flj10986
|
[NCBI]
|
2.7642e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
2.7642e-05
|
|
|
MCCD1
|
[NCBI]
|
2.7642e-05
|
|
|
BBS12
|
[NCBI]
|
2.7642e-05
|
|
|
MFSD8
|
[NCBI]
|
2.7642e-05
|
|
|
MUCDHL
|
[NCBI]
|
2.7642e-05
|
|
|
SPATA16
|
[NCBI]
|
2.7642e-05
|
|
|
MIAT
|
[NCBI]
|
2.7642e-05
|
|
|
ORMDL3
|
[NCBI]
|
2.7642e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
2.74852e-05
|
|
|
SMA3
|
[NCBI]
|
2.74852e-05
|
|
|
FGF20
|
[NCBI]
|
2.7325e-05
|
|
|
GCLM
|
[NCBI]
|
2.7325e-05
|
|
|
CYSLTR1
|
[NCBI]
|
2.7325e-05
|
|
|
MYLK
|
[NCBI]
|
2.7325e-05
|
|
|
ACTN3
|
[NCBI]
|
2.7325e-05
|
|
|
FRZB
|
[NCBI]
|
2.7325e-05
|
|
|
MPO
|
[NCBI]
|
2.72476e-05
|
|
|
DYT1
|
[NCBI]
|
2.70406e-05
|
|
|
KL
|
[NCBI]
|
2.70406e-05
|
|
|
NAT1
|
[NCBI]
|
2.67175e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.66981e-05
|
|
|
INSR
|
[NCBI]
|
2.66135e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.6387e-05
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
2.59743e-05
|
|
|
CCL11
|
[NCBI]
|
2.59743e-05
|
|
|
DIO1
|
[NCBI]
|
2.59743e-05
|
|
|
ASPN
|
[NCBI]
|
2.59743e-05
|
|
|
ICSBP1
|
[NCBI]
|
2.59743e-05
|
|
|
NOS2A
|
[NCBI]
|
2.5901e-05
|
|
|
DMC
|
[NCBI]
|
2.58002e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
2.58002e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
2.58002e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
2.57938e-05
|
|
|
RNASE3
|
[NCBI]
|
2.57928e-05
|
|
|
SRS
|
[NCBI]
|
2.56993e-05
|
|
|
SHH
|
[NCBI]
|
2.53447e-05
|
|
|
RGS4
|
[NCBI]
|
2.47733e-05
|
|
|
PRND
|
[NCBI]
|
2.47733e-05
|
|
|
T
|
[NCBI]
|
2.47733e-05
|
|
|
HMGCR
|
[NCBI]
|
2.47733e-05
|
|
|
OAS1
|
[NCBI]
|
2.47733e-05
|
|
|
POMGNT1
|
[NCBI]
|
2.47733e-05
|
|
|
TYR
|
[NCBI]
|
2.43707e-05
|
|
|
SCD
|
[NCBI]
|
2.43707e-05
|
|
|
IL8
|
[NCBI]
|
2.43431e-05
|
|
|
FRAP1
|
[NCBI]
|
2.42571e-05
|
|
|
SMEI
|
[NCBI]
|
2.42197e-05
|
|
|
NETH
|
[NCBI]
|
2.38376e-05
|
|
|
PARK1
|
[NCBI]
|
2.38376e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
2.38376e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
2.38376e-05
|
|
|
CMT4D
|
[NCBI]
|
2.38376e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
2.38376e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
2.38376e-05
|
|
|
CDB1
|
[NCBI]
|
2.38376e-05
|
|
|
FMD
|
[NCBI]
|
2.38376e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
2.38376e-05
|
|
|
NLRP3
|
[NCBI]
|
2.36931e-05
|
|
|
CILP
|
[NCBI]
|
2.36931e-05
|
|
|
MEIS1
|
[NCBI]
|
2.36931e-05
|
|
|
PPOX
|
[NCBI]
|
2.33911e-05
|
|
|
EPHX1
|
[NCBI]
|
2.29382e-05
|
|
|
FTD
|
[NCBI]
|
2.27907e-05
|
|
|
AHR
|
[NCBI]
|
2.27418e-05
|
|
|
OLIG2
|
[NCBI]
|
2.27125e-05
|
|
|
PDCD5
|
[NCBI]
|
2.27125e-05
|
|
|
SELL
|
[NCBI]
|
2.27125e-05
|
|
|
NDRG1
|
[NCBI]
|
2.27125e-05
|
|
|
MAOA
|
[NCBI]
|
2.2174e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
2.20988e-05
|
|
|
CDL1
|
[NCBI]
|
2.20988e-05
|
|
|
SCZD2
|
[NCBI]
|
2.20988e-05
|
|
|
HTX1
|
[NCBI]
|
2.20988e-05
|
|
|
OCD1
|
[NCBI]
|
2.20988e-05
|
|
|
MSR1
|
[NCBI]
|
2.18154e-05
|
|
|
EN2
|
[NCBI]
|
2.18154e-05
|
|
|
HLA-C
|
[NCBI]
|
2.18154e-05
|
|
|
CALCR
|
[NCBI]
|
2.18154e-05
|
|
|
DRD1
|
[NCBI]
|
2.18154e-05
|
|
|
PDE4D
|
[NCBI]
|
2.18154e-05
|
|
|
PEMT
|
[NCBI]
|
2.16614e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
2.14864e-05
|
|
|
LRRK2
|
[NCBI]
|
2.14783e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
2.13783e-05
|
|
|
AGTR1
|
[NCBI]
|
2.12608e-05
|
|
|
DSG1
|
[NCBI]
|
2.12608e-05
|
|
|
SLC22A1
|
[NCBI]
|
2.09893e-05
|
|
|
SORBS1
|
[NCBI]
|
2.09893e-05
|
|
|
HABP2
|
[NCBI]
|
2.09893e-05
|
|
|
PARK2
|
[NCBI]
|
2.09581e-05
|
|
|
DES
|
[NCBI]
|
2.08717e-05
|
|
|
SMN2
|
[NCBI]
|
2.08717e-05
|
|
|
EDN1
|
[NCBI]
|
2.08717e-05
|
|
|
PSEN1
|
[NCBI]
|
2.08521e-05
|
|
|
HBB
|
[NCBI]
|
2.07998e-05
|
|
|
sotos syndrome
|
[NCBI]
|
2.07249e-05
|
|
|
DFNA6
|
[NCBI]
|
2.05431e-05
|
|
|
CDA
|
[NCBI]
|
2.05431e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
2.05431e-05
|
|
|
MCDC1
|
[NCBI]
|
2.05431e-05
|
|
|
IHPS1
|
[NCBI]
|
2.05431e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
2.05431e-05
|
|
|
MTC
|
[NCBI]
|
2.05431e-05
|
|
|
SNDI
|
[NCBI]
|
2.05431e-05
|
|
|
CDA
|
[NCBI]
|
2.04935e-05
|
|
|
BMP2
|
[NCBI]
|
2.04544e-05
|
|
|
UCP2
|
[NCBI]
|
2.04e-05
|
|
|
POMT1
|
[NCBI]
|
2.02244e-05
|
|
|
TULP1
|
[NCBI]
|
2.02244e-05
|
|
|
MHC2TA
|
[NCBI]
|
2.02244e-05
|
|
|
ME2
|
[NCBI]
|
2.02244e-05
|
|
|
PLAU
|
[NCBI]
|
2.02244e-05
|
|
|
FOXP2
|
[NCBI]
|
2.02244e-05
|
|
|
DHFR
|
[NCBI]
|
2.02142e-05
|
|
|
TYMS
|
[NCBI]
|
2.0181e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
2.01504e-05
|
|
|
LWD
|
[NCBI]
|
2.00922e-05
|
|
|
SNCA
|
[NCBI]
|
1.99664e-05
|
|
|
GNRH1
|
[NCBI]
|
1.97969e-05
|
|
|
LPA
|
[NCBI]
|
1.97677e-05
|
|
|
CCND1
|
[NCBI]
|
1.96655e-05
|
|
|
RTT
|
[NCBI]
|
1.9535e-05
|
|
|
COL18A1
|
[NCBI]
|
1.95128e-05
|
|
|
CYP1A2
|
[NCBI]
|
1.95128e-05
|
|
|
RAPSN
|
[NCBI]
|
1.95128e-05
|
|
|
TPH1
|
[NCBI]
|
1.95128e-05
|
|
|
SLC19A1
|
[NCBI]
|
1.95128e-05
|
|
|
SETDB2
|
[NCBI]
|
1.94517e-05
|
|
|
SPRY3
|
[NCBI]
|
1.94517e-05
|
|
|
mei1, mouse, homolog of
|
[NCBI]
|
1.94517e-05
|
|
|
ste20-related adaptor protein
|
[NCBI]
|
1.94517e-05
|
|
|
ZFAT1
|
[NCBI]
|
1.94517e-05
|
|
|
TMPRSS11A
|
[NCBI]
|
1.94517e-05
|
|
|
CPA5
|
[NCBI]
|
1.94517e-05
|
|
|
g-substrate
|
[NCBI]
|
1.94517e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.94517e-05
|
|
|
KCNK15
|
[NCBI]
|
1.94517e-05
|
|
|
KCNG2
|
[NCBI]
|
1.94517e-05
|
|
|
MAGEB3
|
[NCBI]
|
1.94517e-05
|
|
|
C6ORF15
|
[NCBI]
|
1.94517e-05
|
|
|
NDUFAF1
|
[NCBI]
|
1.94517e-05
|
|
|
LRCH1
|
[NCBI]
|
1.94517e-05
|
|
|
dendritic cell nuclear protein 1
|
[NCBI]
|
1.94517e-05
|
|
|
HS6ST3
|
[NCBI]
|
1.94517e-05
|
|
|
KIAA1109
|
[NCBI]
|
1.94517e-05
|
|
|
PGLYRP3
|
[NCBI]
|
1.94517e-05
|
|
|
pin2-interacting protein 1
|
[NCBI]
|
1.94517e-05
|
|
|
SLC36A3
|
[NCBI]
|
1.94517e-05
|
|
|
KCNS3
|
[NCBI]
|
1.94517e-05
|
|
|
MAGEB4
|
[NCBI]
|
1.94517e-05
|
|
|
TBCD
|
[NCBI]
|
1.94517e-05
|
|
|
selenoprotein, 15-kd
|
[NCBI]
|
1.94517e-05
|
|
|
OAS3
|
[NCBI]
|
1.94517e-05
|
|
|
MMAA
|
[NCBI]
|
1.94517e-05
|
|
|
MAGEB6
|
[NCBI]
|
1.94517e-05
|
|
|
TMEM142C
|
[NCBI]
|
1.94517e-05
|
|
|
BLOC1S3
|
[NCBI]
|
1.94517e-05
|
|
|
DUSP12
|
[NCBI]
|
1.94517e-05
|
|
|
ZC3H12D
|
[NCBI]
|
1.94517e-05
|
|
|
PGLYRP4
|
[NCBI]
|
1.94517e-05
|
|
|
ENDOGL1
|
[NCBI]
|
1.94517e-05
|
|
|
SAGE1
|
[NCBI]
|
1.94517e-05
|
|
|
CHI3L2
|
[NCBI]
|
1.94517e-05
|
|
|
MAGEB5
|
[NCBI]
|
1.94517e-05
|
|
|
breast cancer cell 2
|
[NCBI]
|
1.94517e-05
|
|
|
npl4, s. cerevisiae, homolog of
|
[NCBI]
|
1.94517e-05
|
|
|
COX7B2
|
[NCBI]
|
1.94517e-05
|
|
|
TMEM142B
|
[NCBI]
|
1.94517e-05
|
|
|
kiaa0319 gene
|
[NCBI]
|
1.94517e-05
|
|
|
MAGEC3
|
[NCBI]
|
1.94517e-05
|
|
|
MTNR1B
|
[NCBI]
|
1.94517e-05
|
|
|
GMIP
|
[NCBI]
|
1.94517e-05
|
|
|
intimal thickness-related receptor
|
[NCBI]
|
1.94517e-05
|
|
|
GFPT2
|
[NCBI]
|
1.94517e-05
|
|
|
MBD5
|
[NCBI]
|
1.94517e-05
|
|
|
TXNDC3
|
[NCBI]
|
1.94517e-05
|
|
|
OPD1
|
[NCBI]
|
1.91397e-05
|
|
|
USH3
|
[NCBI]
|
1.91397e-05
|
|
|
XFS
|
[NCBI]
|
1.91397e-05
|
|
|
GRTH
|
[NCBI]
|
1.91397e-05
|
|
|
BMND1
|
[NCBI]
|
1.91397e-05
|
|
|
OPPG
|
[NCBI]
|
1.91397e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
1.91397e-05
|
|
|
MIF
|
[NCBI]
|
1.88479e-05
|
|
|
IL7R
|
[NCBI]
|
1.88479e-05
|
|
|
RAD51
|
[NCBI]
|
1.88479e-05
|
|
|
IFNG
|
[NCBI]
|
1.84264e-05
|
|
|
TNFRSF6
|
[NCBI]
|
1.84264e-05
|
|
|
VCAM1
|
[NCBI]
|
1.82244e-05
|
|
|
USH1C
|
[NCBI]
|
1.82244e-05
|
|
|
LQT3
|
[NCBI]
|
1.78651e-05
|
|
|
AGS1
|
[NCBI]
|
1.78651e-05
|
|
|
JLNS1
|
[NCBI]
|
1.78651e-05
|
|
|
PPS
|
[NCBI]
|
1.78651e-05
|
|
|
WGN1
|
[NCBI]
|
1.78651e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
1.78651e-05
|
|
|
OPD2
|
[NCBI]
|
1.78651e-05
|
|
|
LGMD1B
|
[NCBI]
|
1.78651e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
1.78651e-05
|
|
|
FCMD
|
[NCBI]
|
1.77512e-05
|
|
|
GUCY2D
|
[NCBI]
|
1.76377e-05
|
|
|
KCNE1
|
[NCBI]
|
1.76377e-05
|
|
|
SCN5A
|
[NCBI]
|
1.69262e-05
|
|
|
AR
|
[NCBI]
|
1.68837e-05
|
|
|
CTHM
|
[NCBI]
|
1.67009e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
1.67009e-05
|
|
|
gilbert syndrome
|
[NCBI]
|
1.67009e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.67009e-05
|
|
|
propionic acidemia
|
[NCBI]
|
1.67009e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.67009e-05
|
|
|
PPCD1
|
[NCBI]
|
1.67009e-05
|
|
|
danon disease
|
[NCBI]
|
1.67009e-05
|
|
|
SOST
|
[NCBI]
|
1.67009e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
1.67009e-05
|
|
|
MUC1
|
[NCBI]
|
1.66255e-05
|
|
|
SSTR2
|
[NCBI]
|
1.65606e-05
|
|
|
HLA-G
|
[NCBI]
|
1.65606e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.64152e-05
|
|
|
MAGEA4
|
[NCBI]
|
1.63961e-05
|
|
|
HERC2
|
[NCBI]
|
1.63961e-05
|
|
|
TAAR6
|
[NCBI]
|
1.63961e-05
|
|
|
PTGES2
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEA11
|
[NCBI]
|
1.63961e-05
|
|
|
DCTD
|
[NCBI]
|
1.63961e-05
|
|
|
ALG9
|
[NCBI]
|
1.63961e-05
|
|
|
FXYD6
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEA12
|
[NCBI]
|
1.63961e-05
|
|
|
DLX6
|
[NCBI]
|
1.63961e-05
|
|
|
AKAP10
|
[NCBI]
|
1.63961e-05
|
|
|
parathyroid hormone-responsive b1 gene
|
[NCBI]
|
1.63961e-05
|
|
|
GPR109A
|
[NCBI]
|
1.63961e-05
|
|
|
UGT2A1
|
[NCBI]
|
1.63961e-05
|
|
|
PADI2
|
[NCBI]
|
1.63961e-05
|
|
|
PCDHA8
|
[NCBI]
|
1.63961e-05
|
|
|
SCEL
|
[NCBI]
|
1.63961e-05
|
|
|
CERKL
|
[NCBI]
|
1.63961e-05
|
|
|
ARL11
|
[NCBI]
|
1.63961e-05
|
|
|
CTH
|
[NCBI]
|
1.63961e-05
|
|
|
PDLIM4
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEA3
|
[NCBI]
|
1.63961e-05
|
|
|
POMT2
|
[NCBI]
|
1.63961e-05
|
|
|
AS3MT
|
[NCBI]
|
1.63961e-05
|
|
|
DDX25
|
[NCBI]
|
1.63961e-05
|
|
|
PCDHA10
|
[NCBI]
|
1.63961e-05
|
|
|
SLC24A4
|
[NCBI]
|
1.63961e-05
|
|
|
RBM17
|
[NCBI]
|
1.63961e-05
|
|
|
UGT2B15
|
[NCBI]
|
1.63961e-05
|
|
|
NUP62
|
[NCBI]
|
1.63961e-05
|
|
|
MPST
|
[NCBI]
|
1.63961e-05
|
|
|
ADH6
|
[NCBI]
|
1.63961e-05
|
|
|
NDRG2
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEA10
|
[NCBI]
|
1.63961e-05
|
|
|
MTTQ
|
[NCBI]
|
1.63961e-05
|
|
|
GPR78
|
[NCBI]
|
1.63961e-05
|
|
|
CUL5
|
[NCBI]
|
1.63961e-05
|
|
|
UGT8
|
[NCBI]
|
1.63961e-05
|
|
|
SCG3
|
[NCBI]
|
1.63961e-05
|
|
|
SLC36A2
|
[NCBI]
|
1.63961e-05
|
|
|
DZIP1
|
[NCBI]
|
1.63961e-05
|
|
|
glutathione s-transferase, omega-1
|
[NCBI]
|
1.63961e-05
|
|
|
PCSK4
|
[NCBI]
|
1.63961e-05
|
|
|
SUCLA2
|
[NCBI]
|
1.63961e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
1.63961e-05
|
|
|
NOS1AP
|
[NCBI]
|
1.63961e-05
|
|
|
ZNF365
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEC1
|
[NCBI]
|
1.63961e-05
|
|
|
LXN
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEA6
|
[NCBI]
|
1.63961e-05
|
|
|
USP24
|
[NCBI]
|
1.63961e-05
|
|
|
TRPC5
|
[NCBI]
|
1.63961e-05
|
|
|
WNT5B
|
[NCBI]
|
1.63961e-05
|
|
|
MAGEA9
|
[NCBI]
|
1.63961e-05
|
|
|
CCL26
|
[NCBI]
|
1.63961e-05
|
|
|
GHSR
|
[NCBI]
|
1.6064e-05
|
|
|
DBH
|
[NCBI]
|
1.6064e-05
|
|
|
CNTF
|
[NCBI]
|
1.59641e-05
|
|
|
IL2
|
[NCBI]
|
1.56882e-05
|
|
|
PARK6
|
[NCBI]
|
1.56324e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
1.56324e-05
|
|
|
alexander disease
|
[NCBI]
|
1.56324e-05
|
|
|
GH1
|
[NCBI]
|
1.5622e-05
|
|
|
IL4
|
[NCBI]
|
1.5622e-05
|
|
|
WFS1
|
[NCBI]
|
1.55921e-05
|
|
|
NKX2-1
|
[NCBI]
|
1.55921e-05
|
|
|
DRD2
|
[NCBI]
|
1.55888e-05
|
|
|
GNRHR
|
[NCBI]
|
1.55888e-05
|
|
|
CJD
|
[NCBI]
|
1.55753e-05
|
|
|
AS
|
[NCBI]
|
1.54541e-05
|
|
|
IGF2
|
[NCBI]
|
1.53383e-05
|
|
|
TGFBI
|
[NCBI]
|
1.51427e-05
|
|
|
MFN2
|
[NCBI]
|
1.51427e-05
|
|
|
IRF1
|
[NCBI]
|
1.51427e-05
|
|
|
CDH23
|
[NCBI]
|
1.51427e-05
|
|
|
MTND3
|
[NCBI]
|
1.51427e-05
|
|
|
CYP11B1
|
[NCBI]
|
1.51427e-05
|
|
|
INS
|
[NCBI]
|
1.50605e-05
|
|
|
MMP9
|
[NCBI]
|
1.48528e-05
|
|
|
CRP
|
[NCBI]
|
1.4714e-05
|
|
|
PHA
|
[NCBI]
|
1.46475e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
1.46475e-05
|
|
|
HPC1
|
[NCBI]
|
1.46475e-05
|
|
|
EDC
|
[NCBI]
|
1.46475e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
1.46475e-05
|
|
|
SPCH1
|
[NCBI]
|
1.46475e-05
|
|
|
SCZD1
|
[NCBI]
|
1.46475e-05
|
|
|
NOS3
|
[NCBI]
|
1.46175e-05
|
|
|
LEP
|
[NCBI]
|
1.46113e-05
|
|
|
ITPKC
|
[NCBI]
|
1.44319e-05
|
|
|
SLC34A3
|
[NCBI]
|
1.44319e-05
|
|
|
SYNGR1
|
[NCBI]
|
1.44319e-05
|
|
|
COLEC12
|
[NCBI]
|
1.44319e-05
|
|
|
CTNNA3
|
[NCBI]
|
1.44319e-05
|
|
|
CFHR5
|
[NCBI]
|
1.44319e-05
|
|
|
DNMBP
|
[NCBI]
|
1.44319e-05
|
|
|
ITPR3
|
[NCBI]
|
1.44319e-05
|
|
|
TLR6
|
[NCBI]
|
1.44319e-05
|
|
|
IL1R2
|
[NCBI]
|
1.44319e-05
|
|
|
CRELD1
|
[NCBI]
|
1.44319e-05
|
|
|
CLINT1
|
[NCBI]
|
1.44319e-05
|
|
|
FKBP6
|
[NCBI]
|
1.44319e-05
|
|
|
RGS5
|
[NCBI]
|
1.44319e-05
|
|
|
PCSK5
|
[NCBI]
|
1.44319e-05
|
|
|
NAP1L2
|
[NCBI]
|
1.44319e-05
|
|
|
GPR40
|
[NCBI]
|
1.44319e-05
|
|
|
HCCS
|
[NCBI]
|
1.44319e-05
|
|
|
PLEKHA1
|
[NCBI]
|
1.44319e-05
|
|
|
SLC6A14
|
[NCBI]
|
1.44319e-05
|
|
|
ADNP
|
[NCBI]
|
1.44319e-05
|
|
|
ZNF202
|
[NCBI]
|
1.44319e-05
|
|
|
MAP3K3
|
[NCBI]
|
1.44319e-05
|
|
|
MAGEA8
|
[NCBI]
|
1.44319e-05
|
|
|
CD109
|
[NCBI]
|
1.44319e-05
|
|
|
APBB2
|
[NCBI]
|
1.44319e-05
|
|
|
WWC1
|
[NCBI]
|
1.44319e-05
|
|
|
CHST1
|
[NCBI]
|
1.44319e-05
|
|
|
PRKCH
|
[NCBI]
|
1.44319e-05
|
|
|
TSNAX
|
[NCBI]
|
1.44319e-05
|
|
|
ANXA9
|
[NCBI]
|
1.44319e-05
|
|
|
NELF
|
[NCBI]
|
1.44319e-05
|
|
|
LSP1
|
[NCBI]
|
1.44319e-05
|
|
|
RAD9A
|
[NCBI]
|
1.44319e-05
|
|
|
CFHR3
|
[NCBI]
|
1.44319e-05
|
|
|
LRMP
|
[NCBI]
|
1.44319e-05
|
|
|
PAXIP1
|
[NCBI]
|
1.44319e-05
|
|
|
MUC7
|
[NCBI]
|
1.44319e-05
|
|
|
RDH8
|
[NCBI]
|
1.44319e-05
|
|
|
CH25H
|
[NCBI]
|
1.44319e-05
|
|
|
HYMAI
|
[NCBI]
|
1.44319e-05
|
|
|
CHRM2
|
[NCBI]
|
1.44319e-05
|
|
|
PSMA6
|
[NCBI]
|
1.44319e-05
|
|
|
CCDC50
|
[NCBI]
|
1.44319e-05
|
|
|
NPC1L1
|
[NCBI]
|
1.44319e-05
|
|
|
MAGEA2
|
[NCBI]
|
1.44319e-05
|
|
|
MAGEB2
|
[NCBI]
|
1.44319e-05
|
|
|
OAS2
|
[NCBI]
|
1.44319e-05
|
|
|
MAGEA5
|
[NCBI]
|
1.44319e-05
|
|
|
PHF11
|
[NCBI]
|
1.44319e-05
|
|
|
FGL2
|
[NCBI]
|
1.44319e-05
|
|
|
INPP1
|
[NCBI]
|
1.44319e-05
|
|
|
SLC36A1
|
[NCBI]
|
1.44319e-05
|
|
|
GAPDHS
|
[NCBI]
|
1.44319e-05
|
|
|
CYP26A1
|
[NCBI]
|
1.44319e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.43895e-05
|
|
|
GLO1
|
[NCBI]
|
1.43045e-05
|
|
|
BMP15
|
[NCBI]
|
1.43045e-05
|
|
|
LQT1
|
[NCBI]
|
1.42758e-05
|
|
|
GJA5
|
[NCBI]
|
1.39125e-05
|
|
|
LRP8
|
[NCBI]
|
1.39125e-05
|
|
|
GSTM1
|
[NCBI]
|
1.39125e-05
|
|
|
PTPN1
|
[NCBI]
|
1.39125e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
1.37365e-05
|
|
|
MNS
|
[NCBI]
|
1.37365e-05
|
|
|
FBS
|
[NCBI]
|
1.37365e-05
|
|
|
bladder cancer
|
[NCBI]
|
1.37365e-05
|
|
|
SHEP2
|
[NCBI]
|
1.37365e-05
|
|
|
ELN
|
[NCBI]
|
1.37219e-05
|
|
|
CES1
|
[NCBI]
|
1.3537e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.34411e-05
|
|
|
FABP2
|
[NCBI]
|
1.31766e-05
|
|
|
HMGA2
|
[NCBI]
|
1.31766e-05
|
|
|
NR1I2
|
[NCBI]
|
1.31747e-05
|
|
|
ERMAP
|
[NCBI]
|
1.2986e-05
|
|
|
VN1R1
|
[NCBI]
|
1.2986e-05
|
|
|
PTGDR
|
[NCBI]
|
1.2986e-05
|
|
|
PRSS7
|
[NCBI]
|
1.2986e-05
|
|
|
AHRR
|
[NCBI]
|
1.2986e-05
|
|
|
NPY2R
|
[NCBI]
|
1.2986e-05
|
|
|
SLC14A2
|
[NCBI]
|
1.2986e-05
|
|
|
IL10RA
|
[NCBI]
|
1.2986e-05
|
|
|
RDH12
|
[NCBI]
|
1.2986e-05
|
|
|
MAGEE1
|
[NCBI]
|
1.2986e-05
|
|
|
TRIM21
|
[NCBI]
|
1.2986e-05
|
|
|
MAGEB1
|
[NCBI]
|
1.2986e-05
|
|
|
PCDHA9
|
[NCBI]
|
1.2986e-05
|
|
|
UGT2B7
|
[NCBI]
|
1.2986e-05
|
|
|
GRM7
|
[NCBI]
|
1.2986e-05
|
|
|
PMP2
|
[NCBI]
|
1.2986e-05
|
|
|
ADH7
|
[NCBI]
|
1.2986e-05
|
|
|
LGALS2
|
[NCBI]
|
1.2986e-05
|
|
|
GABRA6
|
[NCBI]
|
1.2986e-05
|
|
|
ABCC11
|
[NCBI]
|
1.2986e-05
|
|
|
NCR3
|
[NCBI]
|
1.2986e-05
|
|
|
PCQAP
|
[NCBI]
|
1.2986e-05
|
|
|
NFKBIL1
|
[NCBI]
|
1.2986e-05
|
|
|
CHI3L1
|
[NCBI]
|
1.2986e-05
|
|
|
MAGED1
|
[NCBI]
|
1.2986e-05
|
|
|
CSTA
|
[NCBI]
|
1.2986e-05
|
|
|
PTPN2
|
[NCBI]
|
1.2986e-05
|
|
|
RAD54L
|
[NCBI]
|
1.2986e-05
|
|
|
lipin 1
|
[NCBI]
|
1.2986e-05
|
|
|
SLC25A12
|
[NCBI]
|
1.2986e-05
|
|
|
TAAR5
|
[NCBI]
|
1.2986e-05
|
|
|
GPR109B
|
[NCBI]
|
1.2986e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.2986e-05
|
|
|
OSBPL5
|
[NCBI]
|
1.2986e-05
|
|
|
GPR74
|
[NCBI]
|
1.2986e-05
|
|
|
PACRG
|
[NCBI]
|
1.2986e-05
|
|
|
MTX1
|
[NCBI]
|
1.2986e-05
|
|
|
FADS1
|
[NCBI]
|
1.2986e-05
|
|
|
LRRFIP1
|
[NCBI]
|
1.2986e-05
|
|
|
ATP1A4
|
[NCBI]
|
1.2986e-05
|
|
|
NLRP1
|
[NCBI]
|
1.2986e-05
|
|
|
CPA4
|
[NCBI]
|
1.2986e-05
|
|
|
ITGA6
|
[NCBI]
|
1.2986e-05
|
|
|
MX1
|
[NCBI]
|
1.2986e-05
|
|
|
MGLL
|
[NCBI]
|
1.2986e-05
|
|
|
IRAK3
|
[NCBI]
|
1.2986e-05
|
|
|
EBN1
|
[NCBI]
|
1.2891e-05
|
|
|
KAL2
|
[NCBI]
|
1.2891e-05
|
|
|
HNA
|
[NCBI]
|
1.2891e-05
|
|
|
BFLS
|
[NCBI]
|
1.2891e-05
|
|
|
ESCS
|
[NCBI]
|
1.2891e-05
|
|
|
TTN
|
[NCBI]
|
1.28304e-05
|
|
|
SMS
|
[NCBI]
|
1.26042e-05
|
|
|
APOH
|
[NCBI]
|
1.24975e-05
|
|
|
IRS2
|
[NCBI]
|
1.24975e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.24632e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.21885e-05
|
|
|
IL18
|
[NCBI]
|
1.21769e-05
|
|
|
CETP
|
[NCBI]
|
1.21769e-05
|
|
|
MTRNR1
|
[NCBI]
|
1.21769e-05
|
|
|
GAPDH
|
[NCBI]
|
1.21361e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
1.21041e-05
|
|
|
PARK8
|
[NCBI]
|
1.21041e-05
|
|
|
PLOSL
|
[NCBI]
|
1.21041e-05
|
|
|
HEPOD
|
[NCBI]
|
1.21041e-05
|
|
|
FMF
|
[NCBI]
|
1.19866e-05
|
|
|
IL12B
|
[NCBI]
|
1.1868e-05
|
|
|
TERC
|
[NCBI]
|
1.1868e-05
|
|
|
SLC2A10
|
[NCBI]
|
1.18454e-05
|
|
|
ITIH4
|
[NCBI]
|
1.18454e-05
|
|
|
GDA
|
[NCBI]
|
1.18454e-05
|
|
|
SYN2
|
[NCBI]
|
1.18454e-05
|
|
|
SEPS1
|
[NCBI]
|
1.18454e-05
|
|
|
CHRNB4
|
[NCBI]
|
1.18454e-05
|
|
|
TBX19
|
[NCBI]
|
1.18454e-05
|
|
|
GABRA2
|
[NCBI]
|
1.18454e-05
|
|
|
COPA
|
[NCBI]
|
1.18454e-05
|
|
|
SH2B3
|
[NCBI]
|
1.18454e-05
|
|
|
MAGEA1
|
[NCBI]
|
1.18454e-05
|
|
|
lipase, congenital absence of pancreatic
|
[NCBI]
|
1.18454e-05
|
|
|
KALRN
|
[NCBI]
|
1.18454e-05
|
|
|
HMCN1
|
[NCBI]
|
1.18454e-05
|
|
|
COH1
|
[NCBI]
|
1.18454e-05
|
|
|
NPY5R
|
[NCBI]
|
1.18454e-05
|
|
|
NHEJ1
|
[NCBI]
|
1.18454e-05
|
|
|
LSS
|
[NCBI]
|
1.18454e-05
|
|
|
SLC9A3R1
|
[NCBI]
|
1.18454e-05
|
|
|
GCSH
|
[NCBI]
|
1.18454e-05
|
|
|
PLUNC
|
[NCBI]
|
1.18454e-05
|
|
|
CES2
|
[NCBI]
|
1.18454e-05
|
|
|
SLC22A3
|
[NCBI]
|
1.18454e-05
|
|
|
CASP12
|
[NCBI]
|
1.18454e-05
|
|
|
FKBP5
|
[NCBI]
|
1.18454e-05
|
|
|
CD24
|
[NCBI]
|
1.18454e-05
|
|
|
MYO10
|
[NCBI]
|
1.18454e-05
|
|
|
MYO9B
|
[NCBI]
|
1.18454e-05
|
|
|
ATP1B1
|
[NCBI]
|
1.18454e-05
|
|
|
ALOX15
|
[NCBI]
|
1.18454e-05
|
|
|
TACR2
|
[NCBI]
|
1.18454e-05
|
|
|
BCOR
|
[NCBI]
|
1.18454e-05
|
|
|
MTF1
|
[NCBI]
|
1.18454e-05
|
|
|
IMPA1
|
[NCBI]
|
1.18454e-05
|
|
|
PI7
|
[NCBI]
|
1.18454e-05
|
|
|
TIRAP
|
[NCBI]
|
1.18454e-05
|
|
|
IMPA2
|
[NCBI]
|
1.18454e-05
|
|
|
KIF11
|
[NCBI]
|
1.18454e-05
|
|
|
TMEM142A
|
[NCBI]
|
1.18454e-05
|
|
|
KMO
|
[NCBI]
|
1.18454e-05
|
|
|
KCNE2
|
[NCBI]
|
1.18454e-05
|
|
|
FDXR
|
[NCBI]
|
1.18454e-05
|
|
|
CRMP1
|
[NCBI]
|
1.18454e-05
|
|
|
CAMTA1
|
[NCBI]
|
1.18454e-05
|
|
|
ANKK1
|
[NCBI]
|
1.18454e-05
|
|
|
ALG6
|
[NCBI]
|
1.18454e-05
|
|
|
GPRK2L
|
[NCBI]
|
1.18454e-05
|
|
|
PREP
|
[NCBI]
|
1.18454e-05
|
|
|
MLX
|
[NCBI]
|
1.18454e-05
|
|
|
SRF
|
[NCBI]
|
1.16676e-05
|
|
|
MLH1
|
[NCBI]
|
1.15814e-05
|
|
|
DNMT3B
|
[NCBI]
|
1.157e-05
|
|
|
CGL2
|
[NCBI]
|
1.13701e-05
|
|
|
EDMD2
|
[NCBI]
|
1.13701e-05
|
|
|
TRPS1
|
[NCBI]
|
1.13701e-05
|
|
|
HSAN1
|
[NCBI]
|
1.13701e-05
|
|
|
G6PD
|
[NCBI]
|
1.11743e-05
|
|
|
GJB2
|
[NCBI]
|
1.10737e-05
|
|
|
CYP2A6
|
[NCBI]
|
1.10044e-05
|
|
|
ICAM1
|
[NCBI]
|
1.10044e-05
|
|
|
TYRP1
|
[NCBI]
|
1.10044e-05
|
|
|
XRCC3
|
[NCBI]
|
1.09066e-05
|
|
|
SGNE1
|
[NCBI]
|
1.09066e-05
|
|
|
DGCR14
|
[NCBI]
|
1.09066e-05
|
|
|
NHLH1
|
[NCBI]
|
1.09066e-05
|
|
|
DLX5
|
[NCBI]
|
1.09066e-05
|
|
|
CHD7
|
[NCBI]
|
1.09066e-05
|
|
|
TAS2R10
|
[NCBI]
|
1.09066e-05
|
|
|
CRYBA4
|
[NCBI]
|
1.09066e-05
|
|
|
TTID
|
[NCBI]
|
1.09066e-05
|
|
|
MEOX1
|
[NCBI]
|
1.09066e-05
|
|
|
KLF11
|
[NCBI]
|
1.09066e-05
|
|
|
TLR10
|
[NCBI]
|
1.09066e-05
|
|
|
DEK
|
[NCBI]
|
1.09066e-05
|
|
|
WNT2
|
[NCBI]
|
1.09066e-05
|
|
|
DPYSL2
|
[NCBI]
|
1.09066e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.09066e-05
|
|
|
PCK1
|
[NCBI]
|
1.09066e-05
|
|
|
VPS13A
|
[NCBI]
|
1.09066e-05
|
|
|
LMNB2
|
[NCBI]
|
1.09066e-05
|
|
|
CHMP4B
|
[NCBI]
|
1.09066e-05
|
|
|
GPX2
|
[NCBI]
|
1.09066e-05
|
|
|
FOXJ1
|
[NCBI]
|
1.09066e-05
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
1.06838e-05
|
|
|
CHAC
|
[NCBI]
|
1.06838e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
1.06838e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
1.06838e-05
|
|
|
CNC1
|
[NCBI]
|
1.06838e-05
|
|
|
FOXO1A
|
[NCBI]
|
1.04756e-05
|
|
|
ALDH2
|
[NCBI]
|
1.04756e-05
|
|
|
FANCA
|
[NCBI]
|
1.04756e-05
|
|
|
CYP3A4
|
[NCBI]
|
1.04756e-05
|
|
|
DDC
|
[NCBI]
|
1.04299e-05
|
|
|
STAT6
|
[NCBI]
|
1.04199e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.03716e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.03716e-05
|
|
|
DGS
|
[NCBI]
|
1.02669e-05
|
|
|
SHOX
|
[NCBI]
|
1.02238e-05
|
|
|
CHEK2
|
[NCBI]
|
1.02238e-05
|
|
|
ADRB2
|
[NCBI]
|
1.02238e-05
|
|
|
TPSAB1
|
[NCBI]
|
1.01111e-05
|
|
|
IRGM
|
[NCBI]
|
1.01111e-05
|
|
|
CCHCR1
|
[NCBI]
|
1.01111e-05
|
|
|
OPRK1
|
[NCBI]
|
1.01111e-05
|
|
|
TRIM32
|
[NCBI]
|
1.01111e-05
|
|
|
LPIN2
|
[NCBI]
|
1.01111e-05
|
|
|
FKBP1B
|
[NCBI]
|
1.01111e-05
|
|
|
S100A7
|
[NCBI]
|
1.01111e-05
|
|
|
IL8RA
|
[NCBI]
|
1.01111e-05
|
|
|
SRD5A1
|
[NCBI]
|
1.01111e-05
|
|
|
USH3A
|
[NCBI]
|
1.01111e-05
|
|
|
PTGFR
|
[NCBI]
|
1.01111e-05
|
|
|
GNS
|
[NCBI]
|
1.01111e-05
|
|
|
HSD17B1
|
[NCBI]
|
1.01111e-05
|
|
|
GALR2
|
[NCBI]
|
1.01111e-05
|
|
|
AGRP
|
[NCBI]
|
1.01111e-05
|
|
|
TAS2R16
|
[NCBI]
|
1.01111e-05
|
|
|
TMPRSS3
|
[NCBI]
|
1.01111e-05
|
|
|
LOXL1
|
[NCBI]
|
1.01111e-05
|
|
|
BAT1
|
[NCBI]
|
1.01111e-05
|
|
|
TAC1
|
[NCBI]
|
1.01111e-05
|
|
|
ME1
|
[NCBI]
|
1.01111e-05
|
|
|
EVPL
|
[NCBI]
|
1.01111e-05
|
|
|
CYP4A11
|
[NCBI]
|
1.01111e-05
|
|
|
POMC
|
[NCBI]
|
1.00667e-05
|
|
|
MLC
|
[NCBI]
|
1.0041e-05
|
|
|
PSNP1
|
[NCBI]
|
1.0041e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
1.0041e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
1.0041e-05
|
|
|
TGD
|
[NCBI]
|
1.0041e-05
|
|
|
hypertension, essential
|
[NCBI]
|
1.0037e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
9.97987e-06
|
|
|
TFPI
|
[NCBI]
|
9.72256e-06
|
|
|
GAL
|
[NCBI]
|
9.51932e-06
|
|
|
CSF2
|
[NCBI]
|
9.51391e-06
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
9.51391e-06
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
9.43776e-06
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
9.43776e-06
|
|
|
HOKPP
|
[NCBI]
|
9.43776e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
9.43776e-06
|
|
|
GCKR
|
[NCBI]
|
9.42286e-06
|
|
|
SEMA7A
|
[NCBI]
|
9.42286e-06
|
|
|
ABCG8
|
[NCBI]
|
9.42286e-06
|
|
|
GAB2
|
[NCBI]
|
9.42286e-06
|
|
|
POR
|
[NCBI]
|
9.42286e-06
|
|
|
PDE11A
|
[NCBI]
|
9.42286e-06
|
|
|
PRLHR
|
[NCBI]
|
9.42286e-06
|
|
|
DDB2
|
[NCBI]
|
9.42286e-06
|
|
|
CFHR1
|
[NCBI]
|
9.42286e-06
|
|
|
AHI1
|
[NCBI]
|
9.42286e-06
|
|
|
HRH1
|
[NCBI]
|
9.42286e-06
|
|
|
MAPK10
|
[NCBI]
|
9.42286e-06
|
|
|
CITED2
|
[NCBI]
|
9.42286e-06
|
|
|
ST8SIA2
|
[NCBI]
|
9.42286e-06
|
|
|
NTS
|
[NCBI]
|
9.42286e-06
|
|
|
MTRR
|
[NCBI]
|
9.42286e-06
|
|
|
ARHGEF6
|
[NCBI]
|
9.42286e-06
|
|
|
ABCA2
|
[NCBI]
|
9.42286e-06
|
|
|
NOTCH4
|
[NCBI]
|
9.42286e-06
|
|
|
DFNA5
|
[NCBI]
|
9.42286e-06
|
|
|
PTF1A
|
[NCBI]
|
9.42286e-06
|
|
|
SDC3
|
[NCBI]
|
9.42286e-06
|
|
|
FCAR
|
[NCBI]
|
9.42286e-06
|
|
|
DNASE1
|
[NCBI]
|
9.42286e-06
|
|
|
DAXX
|
[NCBI]
|
9.42286e-06
|
|
|
IRF2
|
[NCBI]
|
9.42286e-06
|
|
|
PSACH
|
[NCBI]
|
9.39435e-06
|
|
|
TFR2
|
[NCBI]
|
9.29123e-06
|
|
|
AGER
|
[NCBI]
|
9.22246e-06
|
|
|
PRNP
|
[NCBI]
|
8.98416e-06
|
|
|
SEDC
|
[NCBI]
|
8.87087e-06
|
|
|
central core disease of muscle
|
[NCBI]
|
8.87087e-06
|
|
|
ENG
|
[NCBI]
|
8.86489e-06
|
|
|
TYK2
|
[NCBI]
|
8.81782e-06
|
|
|
TRPS1
|
[NCBI]
|
8.81782e-06
|
|
|
GSTT1
|
[NCBI]
|
8.81782e-06
|
|
|
RP1
|
[NCBI]
|
8.81782e-06
|
|
|
MLPH
|
[NCBI]
|
8.81782e-06
|
|
|
PCSK2
|
[NCBI]
|
8.81782e-06
|
|
|
ERBB3
|
[NCBI]
|
8.81782e-06
|
|
|
ADSS
|
[NCBI]
|
8.81782e-06
|
|
|
EPHX2
|
[NCBI]
|
8.81782e-06
|
|
|
CD151
|
[NCBI]
|
8.81782e-06
|
|
|
HAS1
|
[NCBI]
|
8.81782e-06
|
|
|
SYCP3
|
[NCBI]
|
8.81782e-06
|
|
|
TPD52
|
[NCBI]
|
8.81782e-06
|
|
|
SCO2
|
[NCBI]
|
8.81782e-06
|
|
|
CR2
|
[NCBI]
|
8.81782e-06
|
|
|
PTGER2
|
[NCBI]
|
8.81782e-06
|
|
|
AIP
|
[NCBI]
|
8.81782e-06
|
|
|
RAMP2
|
[NCBI]
|
8.81782e-06
|
|
|
EYA4
|
[NCBI]
|
8.81782e-06
|
|
|
AMT
|
[NCBI]
|
8.81782e-06
|
|
|
MAP3K1
|
[NCBI]
|
8.81782e-06
|
|
|
ALMS1
|
[NCBI]
|
8.81782e-06
|
|
|
SCNN1G
|
[NCBI]
|
8.81782e-06
|
|
|
MIRN155
|
[NCBI]
|
8.81782e-06
|
|
|
IMPDH1
|
[NCBI]
|
8.81782e-06
|
|
|
DAZ
|
[NCBI]
|
8.66068e-06
|
|
|
IL2RA
|
[NCBI]
|
8.66068e-06
|
|
|
RELN
|
[NCBI]
|
8.4621e-06
|
|
|
VLDLR
|
[NCBI]
|
8.4621e-06
|
|
|
CPE
|
[NCBI]
|
8.45581e-06
|
|
|
DYX1
|
[NCBI]
|
8.33741e-06
|
|
|
lung cancer
|
[NCBI]
|
8.33741e-06
|
|
|
ALMS
|
[NCBI]
|
8.33741e-06
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
8.33741e-06
|
|
|
LCA1
|
[NCBI]
|
8.33741e-06
|
|
|
PYY
|
[NCBI]
|
8.32362e-06
|
|
|
SLC1A5
|
[NCBI]
|
8.27925e-06
|
|
|
KERA
|
[NCBI]
|
8.27925e-06
|
|
|
CTSS
|
[NCBI]
|
8.27925e-06
|
|
|
TNFSF4
|
[NCBI]
|
8.27925e-06
|
|
|
PLAGL1
|
[NCBI]
|
8.27925e-06
|
|
|
DEFB1
|
[NCBI]
|
8.27925e-06
|
|
|
INPPL1
|
[NCBI]
|
8.27925e-06
|
|
|
MDM1
|
[NCBI]
|
8.27925e-06
|
|
|
BIN1
|
[NCBI]
|
8.27925e-06
|
|
|
SMAD7
|
[NCBI]
|
8.27925e-06
|
|
|
CCL4
|
[NCBI]
|
8.27925e-06
|
|
|
NPPB
|
[NCBI]
|
8.27925e-06
|
|
|
CCL5
|
[NCBI]
|
8.27925e-06
|
|
|
DAP3
|
[NCBI]
|
8.27925e-06
|
|
|
PRKAA2
|
[NCBI]
|
8.27925e-06
|
|
|
LAMC1
|
[NCBI]
|
8.27925e-06
|
|
|
PDCD2
|
[NCBI]
|
8.27925e-06
|
|
|
PRM1
|
[NCBI]
|
8.27925e-06
|
|
|
GATA2
|
[NCBI]
|
8.27925e-06
|
|
|
NRXN1
|
[NCBI]
|
8.27925e-06
|
|
|
TIMP2
|
[NCBI]
|
8.27925e-06
|
|
|
HTR1B
|
[NCBI]
|
8.27925e-06
|
|
|
TRAF1
|
[NCBI]
|
8.27925e-06
|
|
|
TGIF
|
[NCBI]
|
8.27925e-06
|
|
|
IFIH1
|
[NCBI]
|
8.27925e-06
|
|
|
GAS6
|
[NCBI]
|
8.27925e-06
|
|
|
ABCA1
|
[NCBI]
|
8.2689e-06
|
|
|
PTGS2
|
[NCBI]
|
8.0869e-06
|
|
|
SLOS
|
[NCBI]
|
8.00234e-06
|
|
|
WBS
|
[NCBI]
|
8.00234e-06
|
|
|
SMA1
|
[NCBI]
|
7.93113e-06
|
|
|
AANAT
|
[NCBI]
|
7.89781e-06
|
|
|
EVC
|
[NCBI]
|
7.8348e-06
|
|
|
OPTB1
|
[NCBI]
|
7.8348e-06
|
|
|
DFNB1
|
[NCBI]
|
7.8348e-06
|
|
|
GIP
|
[NCBI]
|
7.82774e-06
|
|
|
CRHR2
|
[NCBI]
|
7.79502e-06
|
|
|
MYO15A
|
[NCBI]
|
7.79502e-06
|
|
|
ERCC8
|
[NCBI]
|
7.79502e-06
|
|
|
MLC1
|
[NCBI]
|
7.79502e-06
|
|
|
BRIP1
|
[NCBI]
|
7.79502e-06
|
|
|
GNPAT
|
[NCBI]
|
7.79502e-06
|
|
|
TGFB3
|
[NCBI]
|
7.79502e-06
|
|
|
GABBR2
|
[NCBI]
|
7.79502e-06
|
|
|
MCPH1
|
[NCBI]
|
7.79502e-06
|
|
|
TFAP2B
|
[NCBI]
|
7.79502e-06
|
|
|
BCL2A1
|
[NCBI]
|
7.79502e-06
|
|
|
ASPM
|
[NCBI]
|
7.79502e-06
|
|
|
CCR3
|
[NCBI]
|
7.79502e-06
|
|
|
ZIC3
|
[NCBI]
|
7.79502e-06
|
|
|
ECGF1
|
[NCBI]
|
7.79502e-06
|
|
|
MYF5
|
[NCBI]
|
7.79502e-06
|
|
|
DGAT1
|
[NCBI]
|
7.79502e-06
|
|
|
PEA15
|
[NCBI]
|
7.79502e-06
|
|
|
DNM2
|
[NCBI]
|
7.79502e-06
|
|
|
SLC7A9
|
[NCBI]
|
7.79502e-06
|
|
|
SOAT1
|
[NCBI]
|
7.79502e-06
|
|
|
CX3CR1
|
[NCBI]
|
7.79502e-06
|
|
|
RPL3
|
[NCBI]
|
7.79502e-06
|
|
|
ZNF9
|
[NCBI]
|
7.79502e-06
|
|
|
MS4A2
|
[NCBI]
|
7.79502e-06
|
|
|
PON2
|
[NCBI]
|
7.79502e-06
|
|
|
SPTLC1
|
[NCBI]
|
7.79502e-06
|
|
|
DAO
|
[NCBI]
|
7.54578e-06
|
|
|
NS1
|
[NCBI]
|
7.39858e-06
|
|
|
CYP2D6
|
[NCBI]
|
7.37646e-06
|
|
|
PSAP
|
[NCBI]
|
7.37646e-06
|
|
|
SPDA1
|
[NCBI]
|
7.36075e-06
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
7.36075e-06
|
|
|
CLCN7
|
[NCBI]
|
7.35603e-06
|
|
|
NRF1
|
[NCBI]
|
7.35603e-06
|
|
|
RMRP
|
[NCBI]
|
7.35603e-06
|
|
|
SPINK5
|
[NCBI]
|
7.35603e-06
|
|
|
OGN
|
[NCBI]
|
7.35603e-06
|
|
|
PAPSS2
|
[NCBI]
|
7.35603e-06
|
|
|
PRKAG2
|
[NCBI]
|
7.35603e-06
|
|
|
LTA4H
|
[NCBI]
|
7.35603e-06
|
|
|
ICOS
|
[NCBI]
|
7.35603e-06
|
|
|
PPP1R1B
|
[NCBI]
|
7.35603e-06
|
|
|
CD209
|
[NCBI]
|
7.35603e-06
|
|
|
SPI1
|
[NCBI]
|
7.35603e-06
|
|
|
MEG3
|
[NCBI]
|
7.35603e-06
|
|
|
KLK1
|
[NCBI]
|
7.35603e-06
|
|
|
ART4
|
[NCBI]
|
7.35603e-06
|
|
|
TREX1
|
[NCBI]
|
7.35603e-06
|
|
|
PIGR
|
[NCBI]
|
7.17851e-06
|
|
|
DAZL
|
[NCBI]
|
6.9553e-06
|
|
|
XRCC2
|
[NCBI]
|
6.9553e-06
|
|
|
CHST3
|
[NCBI]
|
6.9553e-06
|
|
|
CEP290
|
[NCBI]
|
6.9553e-06
|
|
|
C5R1
|
[NCBI]
|
6.9553e-06
|
|
|
LDLRAP1
|
[NCBI]
|
6.9553e-06
|
|
|
SFTPA1
|
[NCBI]
|
6.9553e-06
|
|
|
RASSF1
|
[NCBI]
|
6.9553e-06
|
|
|
alsin
|
[NCBI]
|
6.9553e-06
|
|
|
TCF4
|
[NCBI]
|
6.9553e-06
|
|
|
AQP7
|
[NCBI]
|
6.9553e-06
|
|
|
BLMH
|
[NCBI]
|
6.9553e-06
|
|
|
ADH1
|
[NCBI]
|
6.9553e-06
|
|
|
ATXN2
|
[NCBI]
|
6.9553e-06
|
|
|
CBP2
|
[NCBI]
|
6.9553e-06
|
|
|
EBI3
|
[NCBI]
|
6.9553e-06
|
|
|
apert syndrome
|
[NCBI]
|
6.91322e-06
|
|
|
alzheimer disease 3
|
[NCBI]
|
6.91322e-06
|
|
|
A2M
|
[NCBI]
|
6.74003e-06
|
|
|
C3
|
[NCBI]
|
6.74003e-06
|
|
|
CVID
|
[NCBI]
|
6.7114e-06
|
|
|
AURKA
|
[NCBI]
|
6.58735e-06
|
|
|
CD14
|
[NCBI]
|
6.58735e-06
|
|
|
DVL1
|
[NCBI]
|
6.58735e-06
|
|
|
PLA2G7
|
[NCBI]
|
6.58735e-06
|
|
|
CCL18
|
[NCBI]
|
6.58735e-06
|
|
|
PCSK9
|
[NCBI]
|
6.58735e-06
|
|
|
TBXA2R
|
[NCBI]
|
6.58735e-06
|
|
|
CCL3
|
[NCBI]
|
6.58735e-06
|
|
|
SMARCB1
|
[NCBI]
|
6.58735e-06
|
|
|
APOC3
|
[NCBI]
|
6.58735e-06
|
|
|
APP
|
[NCBI]
|
6.54983e-06
|
|
|
STL1
|
[NCBI]
|
6.49039e-06
|
|
|
RP3
|
[NCBI]
|
6.49039e-06
|
|
|
MCOPS7
|
[NCBI]
|
6.49039e-06
|
|
|
homocysteinemia
|
[NCBI]
|
6.49039e-06
|
|
|
COL1A1
|
[NCBI]
|
6.27223e-06
|
|
|
ABCC8
|
[NCBI]
|
6.27223e-06
|
|
|
TBX21
|
[NCBI]
|
6.2478e-06
|
|
|
ATRN
|
[NCBI]
|
6.2478e-06
|
|
|
OTOF
|
[NCBI]
|
6.2478e-06
|
|
|
LIG4
|
[NCBI]
|
6.2478e-06
|
|
|
SOCS2
|
[NCBI]
|
6.2478e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
6.2478e-06
|
|
|
HPSE
|
[NCBI]
|
6.2478e-06
|
|
|
MTND4L
|
[NCBI]
|
6.2478e-06
|
|
|
KCNQ2
|
[NCBI]
|
6.2478e-06
|
|
|
CCKAR
|
[NCBI]
|
6.2478e-06
|
|
|
EPAS1
|
[NCBI]
|
6.2478e-06
|
|
|
POU5F1
|
[NCBI]
|
6.2478e-06
|
|
|
SSTR5
|
[NCBI]
|
6.2478e-06
|
|
|
PGK2
|
[NCBI]
|
6.2478e-06
|
|
|
CDH1
|
[NCBI]
|
6.16237e-06
|
|
|
IGF1
|
[NCBI]
|
6.16237e-06
|
|
|
SLC11A1
|
[NCBI]
|
6.16237e-06
|
|
|
SHBG
|
[NCBI]
|
6.11752e-06
|
|
|
LGMD2C
|
[NCBI]
|
6.0906e-06
|
|
|
BMPR1A
|
[NCBI]
|
5.93309e-06
|
|
|
NFKBIA
|
[NCBI]
|
5.93309e-06
|
|
|
MC3R
|
[NCBI]
|
5.93309e-06
|
|
|
ADRB1
|
[NCBI]
|
5.93309e-06
|
|
|
THBD
|
[NCBI]
|
5.93309e-06
|
|
|
PCSK1
|
[NCBI]
|
5.93309e-06
|
|
|
ATXN3
|
[NCBI]
|
5.93309e-06
|
|
|
CYP2C9
|
[NCBI]
|
5.93309e-06
|
|
|
CNR1
|
[NCBI]
|
5.93309e-06
|
|
|
TLR1
|
[NCBI]
|
5.93309e-06
|
|
|
ALOX5
|
[NCBI]
|
5.93309e-06
|
|
|
TERF1
|
[NCBI]
|
5.93309e-06
|
|
|
NCF1
|
[NCBI]
|
5.93309e-06
|
|
|
PRTN3
|
[NCBI]
|
5.93309e-06
|
|
|
GPR24
|
[NCBI]
|
5.93309e-06
|
|
|
CUL1
|
[NCBI]
|
5.93309e-06
|
|
|
ITGB3
|
[NCBI]
|
5.89319e-06
|
|
|
CYP19A1
|
[NCBI]
|
5.76314e-06
|
|
|
APOM
|
[NCBI]
|
5.6403e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
5.6403e-06
|
|
|
ANGPTL4
|
[NCBI]
|
5.6403e-06
|
|
|
CBR1
|
[NCBI]
|
5.6403e-06
|
|
|
MYO6
|
[NCBI]
|
5.6403e-06
|
|
|
MEF2A
|
[NCBI]
|
5.6403e-06
|
|
|
USH2A
|
[NCBI]
|
5.6403e-06
|
|
|
ADAM10
|
[NCBI]
|
5.6403e-06
|
|
|
RNASEL
|
[NCBI]
|
5.6403e-06
|
|
|
TAZ
|
[NCBI]
|
5.6403e-06
|
|
|
COL11A1
|
[NCBI]
|
5.6403e-06
|
|
|
GNB3
|
[NCBI]
|
5.6403e-06
|
|
|
STX1A
|
[NCBI]
|
5.6403e-06
|
|
|
CALM1
|
[NCBI]
|
5.6403e-06
|
|
|
NSD1
|
[NCBI]
|
5.6403e-06
|
|
|
PEG3
|
[NCBI]
|
5.6403e-06
|
|
|
GJA4
|
[NCBI]
|
5.6403e-06
|
|
|
UGT1A1
|
[NCBI]
|
5.636e-06
|
|
|
BTC
|
[NCBI]
|
5.636e-06
|
|
|
PGR
|
[NCBI]
|
5.60649e-06
|
|
|
UCHL1
|
[NCBI]
|
5.36697e-06
|
|
|
SPHK1
|
[NCBI]
|
5.36697e-06
|
|
|
ITGB4
|
[NCBI]
|
5.36697e-06
|
|
|
TRHR
|
[NCBI]
|
5.36697e-06
|
|
|
SQSTM1
|
[NCBI]
|
5.36697e-06
|
|
|
LTF
|
[NCBI]
|
5.36697e-06
|
|
|
GLDC
|
[NCBI]
|
5.36697e-06
|
|
|
SREBF1
|
[NCBI]
|
5.36697e-06
|
|
|
TSHB
|
[NCBI]
|
5.36697e-06
|
|
|
TTR
|
[NCBI]
|
5.36353e-06
|
|
|
PARK2
|
[NCBI]
|
5.35435e-06
|
|
|
CDKN2A
|
[NCBI]
|
5.30572e-06
|
|
|
GCCR
|
[NCBI]
|
5.27116e-06
|
|
|
CCL17
|
[NCBI]
|
5.27116e-06
|
|
|
SOD2
|
[NCBI]
|
5.22737e-06
|
|
|
FOXL2
|
[NCBI]
|
5.11107e-06
|
|
|
PCDH15
|
[NCBI]
|
5.11107e-06
|
|
|
XRCC9
|
[NCBI]
|
5.11107e-06
|
|
|
ID2
|
[NCBI]
|
5.11107e-06
|
|
|
FRAXE
|
[NCBI]
|
5.11107e-06
|
|
|
COL11A2
|
[NCBI]
|
5.11107e-06
|
|
|
TERF2
|
[NCBI]
|
5.11107e-06
|
|
|
FUT2
|
[NCBI]
|
5.11107e-06
|
|
|
TNFSF10
|
[NCBI]
|
5.08264e-06
|
|
|
APOD
|
[NCBI]
|
5.04093e-06
|
|
|
CCL2
|
[NCBI]
|
5.04093e-06
|
|
|
CMD1A
|
[NCBI]
|
5.01531e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
5.01531e-06
|
|
|
CCR5
|
[NCBI]
|
4.9295e-06
|
|
|
CCNE1
|
[NCBI]
|
4.87085e-06
|
|
|
CHRNA4
|
[NCBI]
|
4.87085e-06
|
|
|
SN
|
[NCBI]
|
4.87085e-06
|
|
|
PHOX2B
|
[NCBI]
|
4.87085e-06
|
|
|
PPARD
|
[NCBI]
|
4.87085e-06
|
|
|
CACNA1S
|
[NCBI]
|
4.87085e-06
|
|
|
CYP2C19
|
[NCBI]
|
4.87085e-06
|
|
|
CSF1
|
[NCBI]
|
4.87085e-06
|
|
|
PHB
|
[NCBI]
|
4.87085e-06
|
|
|
ERCC6
|
[NCBI]
|
4.87085e-06
|
|
|
DMBT1
|
[NCBI]
|
4.87085e-06
|
|
|
GAD2
|
[NCBI]
|
4.87085e-06
|
|
|
NNMT
|
[NCBI]
|
4.87085e-06
|
|
|
CYGB
|
[NCBI]
|
4.87085e-06
|
|
|
HSD11B1
|
[NCBI]
|
4.87085e-06
|
|
|
DCK
|
[NCBI]
|
4.737e-06
|
|
|
DRD4
|
[NCBI]
|
4.71366e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
4.69414e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
4.69414e-06
|
|
|
SLC2A1
|
[NCBI]
|
4.64481e-06
|
|
|
CHRNA1
|
[NCBI]
|
4.64481e-06
|
|
|
CTSD
|
[NCBI]
|
4.64481e-06
|
|
|
GPR54
|
[NCBI]
|
4.64481e-06
|
|
|
CR1
|
[NCBI]
|
4.64481e-06
|
|
|
DRD3
|
[NCBI]
|
4.64481e-06
|
|
|
DCX
|
[NCBI]
|
4.64481e-06
|
|
|
PYGM
|
[NCBI]
|
4.64481e-06
|
|
|
FSHR
|
[NCBI]
|
4.60911e-06
|
|
|
MJD
|
[NCBI]
|
4.54134e-06
|
|
|
PNMT
|
[NCBI]
|
4.52263e-06
|
|
|
IL3
|
[NCBI]
|
4.50675e-06
|
|
|
FAAH
|
[NCBI]
|
4.45023e-06
|
|
|
PDGFRA
|
[NCBI]
|
4.43166e-06
|
|
|
MPL
|
[NCBI]
|
4.43166e-06
|
|
|
GHRHR
|
[NCBI]
|
4.43166e-06
|
|
|
ADAMTS13
|
[NCBI]
|
4.43166e-06
|
|
|
ASIP
|
[NCBI]
|
4.43166e-06
|
|
|
MEB
|
[NCBI]
|
4.38982e-06
|
|
|
WFS1
|
[NCBI]
|
4.38982e-06
|
|
|
VAMP2
|
[NCBI]
|
4.23028e-06
|
|
|
PLAT
|
[NCBI]
|
4.23028e-06
|
|
|
AACT
|
[NCBI]
|
4.23028e-06
|
|
|
TCOF1
|
[NCBI]
|
4.23028e-06
|
|
|
SDHD
|
[NCBI]
|
4.23028e-06
|
|
|
RHD
|
[NCBI]
|
4.23028e-06
|
|
|
GJB3
|
[NCBI]
|
4.23028e-06
|
|
|
SLC5A7
|
[NCBI]
|
4.23028e-06
|
|
|
PARP1
|
[NCBI]
|
4.21212e-06
|
|
|
COH1
|
[NCBI]
|
4.10141e-06
|
|
|
HNF1B
|
[NCBI]
|
4.03969e-06
|
|
|
EMD
|
[NCBI]
|
4.03969e-06
|
|
|
IL12A
|
[NCBI]
|
4.03969e-06
|
|
|
PMM2
|
[NCBI]
|
4.03969e-06
|
|
|
FFI
|
[NCBI]
|
4.03202e-06
|
|
|
TSHR
|
[NCBI]
|
4.02558e-06
|
|
|
IAPP
|
[NCBI]
|
4.0145e-06
|
|
|
HBA1
|
[NCBI]
|
4.0145e-06
|
|
|
PDCD8
|
[NCBI]
|
3.97878e-06
|
|
|
NF1
|
[NCBI]
|
3.87211e-06
|
|
|
MMP1
|
[NCBI]
|
3.85903e-06
|
|
|
EGR2
|
[NCBI]
|
3.85903e-06
|
|
|
SLC12A3
|
[NCBI]
|
3.85903e-06
|
|
|
GSK3B
|
[NCBI]
|
3.85903e-06
|
|
|
SLC3A1
|
[NCBI]
|
3.85903e-06
|
|
|
KLK7
|
[NCBI]
|
3.68752e-06
|
|
|
SLN
|
[NCBI]
|
3.68752e-06
|
|
|
PMS2
|
[NCBI]
|
3.68752e-06
|
|
|
SCN1A
|
[NCBI]
|
3.68752e-06
|
|
|
MECP2
|
[NCBI]
|
3.68585e-06
|
|
|
MFS
|
[NCBI]
|
3.62064e-06
|
|
|
AHSG
|
[NCBI]
|
3.52449e-06
|
|
|
CTSK
|
[NCBI]
|
3.52449e-06
|
|
|
NOS1
|
[NCBI]
|
3.52449e-06
|
|
|
TSG101
|
[NCBI]
|
3.52449e-06
|
|
|
OPA1
|
[NCBI]
|
3.52449e-06
|
|
|
PPARGC1A
|
[NCBI]
|
3.52449e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
3.39909e-06
|
|
|
AICDA
|
[NCBI]
|
3.36934e-06
|
|
|
GJA8
|
[NCBI]
|
3.36934e-06
|
|
|
PTCH1
|
[NCBI]
|
3.36934e-06
|
|
|
GPX1
|
[NCBI]
|
3.36934e-06
|
|
|
POAG
|
[NCBI]
|
3.32337e-06
|
|
|
UCP3
|
[NCBI]
|
3.27325e-06
|
|
|
TAF1
|
[NCBI]
|
3.22152e-06
|
|
|
SMPD1
|
[NCBI]
|
3.22152e-06
|
|
|
APEX
|
[NCBI]
|
3.22152e-06
|
|
|
IGF2R
|
[NCBI]
|
3.22152e-06
|
|
|
ARSB
|
[NCBI]
|
3.22152e-06
|
|
|
AKR1B1
|
[NCBI]
|
3.21424e-06
|
|
|
HLA-A
|
[NCBI]
|
3.12354e-06
|
|
|
GHRH
|
[NCBI]
|
3.10518e-06
|
|
|
RSTS
|
[NCBI]
|
3.09065e-06
|
|
|
CHGA
|
[NCBI]
|
3.08055e-06
|
|
|
GSTP1
|
[NCBI]
|
3.08055e-06
|
|
|
RYR2
|
[NCBI]
|
3.08055e-06
|
|
|
PLD2
|
[NCBI]
|
3.08055e-06
|
|
|
PTX3
|
[NCBI]
|
3.08055e-06
|
|
|
BCR
|
[NCBI]
|
3.07992e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
3.05085e-06
|
|
|
SMN1
|
[NCBI]
|
2.97957e-06
|
|
|
ADH5
|
[NCBI]
|
2.94597e-06
|
|
|
NPC1
|
[NCBI]
|
2.94597e-06
|
|
|
RBP4
|
[NCBI]
|
2.94597e-06
|
|
|
CD40LG
|
[NCBI]
|
2.94597e-06
|
|
|
GPC3
|
[NCBI]
|
2.94597e-06
|
|
|
TGFBR2
|
[NCBI]
|
2.94597e-06
|
|
|
MSH6
|
[NCBI]
|
2.94597e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.94597e-06
|
|
|
DPYD
|
[NCBI]
|
2.94597e-06
|
|
|
STAT4
|
[NCBI]
|
2.94597e-06
|
|
|
RB1
|
[NCBI]
|
2.84864e-06
|
|
|
MET
|
[NCBI]
|
2.8174e-06
|
|
|
PTPN11
|
[NCBI]
|
2.8174e-06
|
|
|
CAPN3
|
[NCBI]
|
2.8174e-06
|
|
|
CDKN1B
|
[NCBI]
|
2.8174e-06
|
|
|
COL6A1
|
[NCBI]
|
2.8174e-06
|
|
|
CRY1
|
[NCBI]
|
2.8174e-06
|
|
|
MEFV
|
[NCBI]
|
2.8174e-06
|
|
|
IL1A
|
[NCBI]
|
2.8174e-06
|
|
|
PCD
|
[NCBI]
|
2.81605e-06
|
|
|
MAG
|
[NCBI]
|
2.80946e-06
|
|
|
ABCC2
|
[NCBI]
|
2.77388e-06
|
|
|
BANF1
|
[NCBI]
|
2.69446e-06
|
|
|
HLA-B
|
[NCBI]
|
2.69446e-06
|
|
|
CXCL12
|
[NCBI]
|
2.69446e-06
|
|
|
COL10A1
|
[NCBI]
|
2.69446e-06
|
|
|
FASN
|
[NCBI]
|
2.69446e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
2.66129e-06
|
|
|
RTS
|
[NCBI]
|
2.66129e-06
|
|
|
JPS
|
[NCBI]
|
2.66129e-06
|
|
|
SLE
|
[NCBI]
|
2.51777e-06
|
|
|
SLC6A4
|
[NCBI]
|
2.51406e-06
|
|
|
phenylketonuria
|
[NCBI]
|
2.49552e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.4642e-06
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.4642e-06
|
|
|
ERCC5
|
[NCBI]
|
2.4642e-06
|
|
|
QTRT1
|
[NCBI]
|
2.4642e-06
|
|
|
DM2
|
[NCBI]
|
2.46353e-06
|
|
|
AIRE
|
[NCBI]
|
2.45656e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.45584e-06
|
|
|
LDLR
|
[NCBI]
|
2.38878e-06
|
|
|
GDF5
|
[NCBI]
|
2.35629e-06
|
|
|
SLAMF1
|
[NCBI]
|
2.35629e-06
|
|
|
CXCR4
|
[NCBI]
|
2.35629e-06
|
|
|
TACR1
|
[NCBI]
|
2.35629e-06
|
|
|
STAT3
|
[NCBI]
|
2.32207e-06
|
|
|
DYT1
|
[NCBI]
|
2.27636e-06
|
|
|
ALGS1
|
[NCBI]
|
2.27636e-06
|
|
|
aortic valve disease
|
[NCBI]
|
2.27636e-06
|
|
|
ABCC6
|
[NCBI]
|
2.25285e-06
|
|
|
FGF10
|
[NCBI]
|
2.25285e-06
|
|
|
coproporphyria
|
[NCBI]
|
2.25285e-06
|
|
|
RAG1
|
[NCBI]
|
2.15365e-06
|
|
|
ATP7A
|
[NCBI]
|
2.15365e-06
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.09933e-06
|
|
|
PTPRC
|
[NCBI]
|
2.05846e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
2.03533e-06
|
|
|
SLC1A2
|
[NCBI]
|
1.96708e-06
|
|
|
PDYN
|
[NCBI]
|
1.96708e-06
|
|
|
PKLR
|
[NCBI]
|
1.96708e-06
|
|
|
GAMT
|
[NCBI]
|
1.96708e-06
|
|
|
EDNRB
|
[NCBI]
|
1.96708e-06
|
|
|
CSA
|
[NCBI]
|
1.93197e-06
|
|
|
NPS
|
[NCBI]
|
1.93197e-06
|
|
|
GNMT
|
[NCBI]
|
1.87934e-06
|
|
|
ATP7B
|
[NCBI]
|
1.87934e-06
|
|
|
FY
|
[NCBI]
|
1.87934e-06
|
|
|
ALK
|
[NCBI]
|
1.83184e-06
|
|
|
SIRT1
|
[NCBI]
|
1.79505e-06
|
|
|
LIFR
|
[NCBI]
|
1.79505e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.77389e-06
|
|
|
LNS
|
[NCBI]
|
1.77389e-06
|
|
|
BRRS
|
[NCBI]
|
1.77389e-06
|
|
|
EV
|
[NCBI]
|
1.76405e-06
|
|
|
SOD1
|
[NCBI]
|
1.73149e-06
|
|
|
PCOS1
|
[NCBI]
|
1.72875e-06
|
|
|
ABCA4
|
[NCBI]
|
1.71406e-06
|
|
|
MMP3
|
[NCBI]
|
1.71406e-06
|
|
|
LCAT
|
[NCBI]
|
1.68601e-06
|
|
|
RA
|
[NCBI]
|
1.66938e-06
|
|
|
PMP22
|
[NCBI]
|
1.66191e-06
|
|
|
AMACR
|
[NCBI]
|
1.63621e-06
|
|
|
MTCYB
|
[NCBI]
|
1.63621e-06
|
|
|
EPOR
|
[NCBI]
|
1.63409e-06
|
|
|
MDD
|
[NCBI]
|
1.62503e-06
|
|
|
HNPP
|
[NCBI]
|
1.6247e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
1.6247e-06
|
|
|
temporal arteritis
|
[NCBI]
|
1.60879e-06
|
|
|
SST
|
[NCBI]
|
1.60643e-06
|
|
|
PEDF
|
[NCBI]
|
1.57891e-06
|
|
|
POLG
|
[NCBI]
|
1.56137e-06
|
|
|
SOX9
|
[NCBI]
|
1.56137e-06
|
|
|
CYP17A1
|
[NCBI]
|
1.56137e-06
|
|
|
PAM
|
[NCBI]
|
1.5377e-06
|
|
|
RUNX1
|
[NCBI]
|
1.4894e-06
|
|
|
TCRA
|
[NCBI]
|
1.4894e-06
|
|
|
AMC
|
[NCBI]
|
1.48403e-06
|
|
|
MAPK14
|
[NCBI]
|
1.42018e-06
|
|
|
HFE
|
[NCBI]
|
1.36434e-06
|
|
|
ERBB2
|
[NCBI]
|
1.35361e-06
|
|
|
L1CAM
|
[NCBI]
|
1.35361e-06
|
|
|
SCA7
|
[NCBI]
|
1.35154e-06
|
|
|
CPI
|
[NCBI]
|
1.32256e-06
|
|
|
ALAD
|
[NCBI]
|
1.28956e-06
|
|
|
BWS
|
[NCBI]
|
1.23807e-06
|
|
|
AKT1
|
[NCBI]
|
1.22794e-06
|
|
|
HCRT
|
[NCBI]
|
1.22794e-06
|
|
|
von willebrand disease
|
[NCBI]
|
1.15129e-06
|
|
|
BCHE
|
[NCBI]
|
1.14552e-06
|
|
|
SH2D1A
|
[NCBI]
|
1.11162e-06
|
|
|
RCC1
|
[NCBI]
|
1.10984e-06
|
|
|
DNMT1
|
[NCBI]
|
1.08668e-06
|
|
|
SPP1
|
[NCBI]
|
1.07039e-06
|
|
|
RIPK1
|
[NCBI]
|
1.05674e-06
|
|
|
CFB
|
[NCBI]
|
1.05674e-06
|
|
|
PPARA
|
[NCBI]
|
1.01455e-06
|
|
|
FLNA
|
[NCBI]
|
1.00394e-06
|
|
|
B2M
|
[NCBI]
|
1.00394e-06
|
|
|
FGFR1
|
[NCBI]
|
9.54578e-07
|
|
|
PROCR
|
[NCBI]
|
9.53144e-07
|
|
|
KITLG
|
[NCBI]
|
9.44489e-07
|
|
|
MSH2
|
[NCBI]
|
9.04279e-07
|
|
|
SLC18A2
|
[NCBI]
|
9.04279e-07
|
|
|
KCNH2
|
[NCBI]
|
8.98596e-07
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
8.97265e-07
|
|
|
PGM1
|
[NCBI]
|
8.57279e-07
|
|
|
LBR
|
[NCBI]
|
8.57279e-07
|
|
|
PLP1
|
[NCBI]
|
8.57279e-07
|
|
|
PARG
|
[NCBI]
|
8.57279e-07
|
|
|
OPMD
|
[NCBI]
|
8.46003e-07
|
|
|
ADHD
|
[NCBI]
|
8.46003e-07
|
|
|
ALPS
|
[NCBI]
|
8.46003e-07
|
|
|
DFFB
|
[NCBI]
|
8.12078e-07
|
|
|
REN
|
[NCBI]
|
8.12078e-07
|
|
|
BPES
|
[NCBI]
|
8.01229e-07
|
|
|
SLC2A2
|
[NCBI]
|
7.68617e-07
|
|
|
RPGR
|
[NCBI]
|
7.68617e-07
|
|
|
BCNS
|
[NCBI]
|
7.6777e-07
|
|
|
PLTP
|
[NCBI]
|
7.66081e-07
|
|
|
MCP
|
[NCBI]
|
7.02697e-07
|
|
|
KCNQ1
|
[NCBI]
|
6.86683e-07
|
|
|
HD
|
[NCBI]
|
6.7438e-07
|
|
|
PEE1
|
[NCBI]
|
6.56894e-07
|
|
|
DBI
|
[NCBI]
|
6.53639e-07
|
|
|
AQP4
|
[NCBI]
|
6.48102e-07
|
|
|
PKD2
|
[NCBI]
|
6.48102e-07
|
|
|
HNF4A
|
[NCBI]
|
6.48102e-07
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
6.11045e-07
|
|
|
PTEN
|
[NCBI]
|
5.82097e-07
|
|
|
IRS1
|
[NCBI]
|
5.41314e-07
|
|
|
HMBS
|
[NCBI]
|
5.3985e-07
|
|
|
CTGF
|
[NCBI]
|
5.26489e-07
|
|
|
PRLH
|
[NCBI]
|
5.08551e-07
|
|
|
BCL2
|
[NCBI]
|
5.08551e-07
|
|
|
CD
|
[NCBI]
|
4.94737e-07
|
|
|
CES
|
[NCBI]
|
4.79954e-07
|
|
|
PMCH
|
[NCBI]
|
4.78786e-07
|
|
|
SOCS3
|
[NCBI]
|
4.77133e-07
|
|
|
LIPC
|
[NCBI]
|
4.77133e-07
|
|
|
CD36
|
[NCBI]
|
4.77133e-07
|
|
|
GC
|
[NCBI]
|
4.70256e-07
|
|
|
TG
|
[NCBI]
|
4.3342e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.18179e-07
|
|
|
HPS
|
[NCBI]
|
4.09843e-07
|
|
|
UCP1
|
[NCBI]
|
4.00911e-07
|
|
|
THPO
|
[NCBI]
|
3.90568e-07
|
|
|
ANG
|
[NCBI]
|
3.64155e-07
|
|
|
ABCD1
|
[NCBI]
|
3.64155e-07
|
|
|
HGPS
|
[NCBI]
|
3.54118e-07
|
|
|
CHH
|
[NCBI]
|
3.54118e-07
|
|
|
TBP
|
[NCBI]
|
3.51802e-07
|
|
|
TERT
|
[NCBI]
|
3.50628e-07
|
|
|
TLR3
|
[NCBI]
|
3.38906e-07
|
|
|
RHO
|
[NCBI]
|
3.36006e-07
|
|
|
H6PD
|
[NCBI]
|
3.14789e-07
|
|
|
TSC2
|
[NCBI]
|
3.14789e-07
|
|
|
MC4R
|
[NCBI]
|
3.14789e-07
|
|
|
KDR
|
[NCBI]
|
3.05297e-07
|
|
|
MEN2A
|
[NCBI]
|
2.99241e-07
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
2.99241e-07
|
|
|
NR0B2
|
[NCBI]
|
2.91774e-07
|
|
|
THRB
|
[NCBI]
|
2.91774e-07
|
|
|
VCP
|
[NCBI]
|
2.91774e-07
|
|
|
ACADM
|
[NCBI]
|
2.88139e-07
|
|
|
PAX6
|
[NCBI]
|
2.48932e-07
|
|
|
BRCA2
|
[NCBI]
|
2.47534e-07
|
|
|
FGFR3
|
[NCBI]
|
2.32348e-07
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.28081e-07
|
|
|
RYR1
|
[NCBI]
|
2.10159e-07
|
|
|
TPO
|
[NCBI]
|
2.04996e-07
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
2.04727e-07
|
|
|
FGF8
|
[NCBI]
|
1.92234e-07
|
|
|
HP
|
[NCBI]
|
1.88462e-07
|
|
|
MTTL1
|
[NCBI]
|
1.7525e-07
|
|
|
SLC11A2
|
[NCBI]
|
1.7525e-07
|
|
|
apc gene
|
[NCBI]
|
1.72631e-07
|
|
|
SLC6A3
|
[NCBI]
|
1.71488e-07
|
|
|
CMT1A
|
[NCBI]
|
1.64777e-07
|
|
|
IDUA
|
[NCBI]
|
1.59185e-07
|
|
|
MITF
|
[NCBI]
|
1.58944e-07
|
|
|
ADM
|
[NCBI]
|
1.33584e-07
|
|
|
factor v deficiency
|
[NCBI]
|
1.29722e-07
|
|
|
BSG
|
[NCBI]
|
1.29722e-07
|
|
|
BRCA1
|
[NCBI]
|
1.04371e-07
|
|
|
RP
|
[NCBI]
|
1.0382e-07
|
|
|
GJB1
|
[NCBI]
|
9.68013e-08
|
|
|
TP53
|
[NCBI]
|
9.19601e-08
|
|
|
ATM
|
[NCBI]
|
8.77748e-08
|
|
|
PXE
|
[NCBI]
|
8.18613e-08
|
|
|
VHL
|
[NCBI]
|
8.0882e-08
|
|
|
PLN
|
[NCBI]
|
8.0882e-08
|
|
|
JMML
|
[NCBI]
|
5.81912e-08
|
|
|
wilson disease
|
[NCBI]
|
5.81912e-08
|
|
|
GTS
|
[NCBI]
|
5.65079e-08
|
|
|
GBA
|
[NCBI]
|
4.44928e-08
|
|
|
WRN
|
[NCBI]
|
4.02868e-08
|
|
|
PI
|
[NCBI]
|
3.66418e-08
|
|
|
alopecia, androgenetic
|
[NCBI]
|
3.2445e-08
|
|
|
FBN1
|
[NCBI]
|
3.04161e-08
|
|
|
LS
|
[NCBI]
|
2.55565e-08
|
|
|
MPZ
|
[NCBI]
|
1.94884e-08
|
|
|
GCK
|
[NCBI]
|
1.94884e-08
|
|
|
lynch syndrome i
|
[NCBI]
|
1.85677e-08
|
|
|
SCA2
|
[NCBI]
|
1.85677e-08
|
|
|
CALCRL
|
[NCBI]
|
1.61937e-08
|
|
|
FGF1
|
[NCBI]
|
1.49042e-08
|
|
|
COMP
|
[NCBI]
|
2.97889e-09
|
|
|
ABCB11
|
[NCBI]
|
2.83028e-09
|
|
|
CCD
|
[NCBI]
|
2.47554e-09
|
|
|
AT
|
[NCBI]
|
2.01625e-10
|
|